Epigenetic reprogramming involving histone H3 variants, histone modifications and DNA methylation in mouse zygotes by Lan, Jie
  
Epigenetic reprogramming involving histone H3 
variants, histone modifications and DNA 
methylation in mouse zygotes 
 
 
 
 
 
 
 
Dissertation 
zur Erlangung des Grades 
des Doktors der Naturwissenschaften  
der Naturwissenschaftlich-Technischen Falkultät III 
Chemie, Pharmazie, Bio- und Werkstoffwissenschaften  
der Universität des Saarlandes 
 
 
 
 
 
 
 
 
Von 
 
 
Jie Lan 
 
 
Saarbrücken 
 
September, 2015  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tag des Kolloquiums:      ………………………….…………………………….…                                                                                                                                    
 
 
Dekan:                              ………………………….…………………………….…                         
 
 
Berichterstatter:               ………………………….…………………………….…             
 
 
 
                                                             ………………………….…………………………….… 
 
 
 
                                                             ………………………….…………………………….… 
 
 
Vorsitz:                            ………………………….…………………………….… 
 
 
Akad. Mitarbeiter:           ………………………….…………………………….… 
Am Dienstag, dem 19. Januar 2016 
Prof. Dr.-Ing. Dirk Bähre 
Prof. Dr. Jörn Walter 
Prof. Dr. Uli Müller 
Prof. Dr. Manfred J. Schmitt 
Dr. Sonja Kessler 
  
 
 
 
 
 
 
 
 
 
 
 
 
My Motto of life 
 
 
 
Do not aim for success if you want it. Just do what you love 
and believe in, and it will come naturally. 
 
 
 
                                                                                                                                                                                                                                        
  
Acknowledgement 
First and above all, I would like to express my special appreciation to my Doktorvater, Prof. 
Dr. Jörn Walter, for giving me the opportunity to complete my PhD thesis in his lab. I also 
want to thank him for great encouragement, invaluable guidance as well as several profound 
discussions. As an excellent and outstanding scientist, he could always hit the key points and 
come up with brilliant ideas in an incredibly fast way, which gives me a very deep 
impression. For this, I would like to give him a nickname “Blitzdenker”. What I learned from 
all his good qualities is really beneficial to both my life and work in the future.   
As my second surpervisor, Prof. Dr. Uli Müller, he really deserves great thanks from 
me for the full support including both the experimental questions and devices. Also, an 
unforgettable discussion with him about the regulation of TDG by acetylation benefited me a 
lot, for example, how to design the experiment in a well-organized way and avoid neglecting 
any small but critical points.  
I want to give special thanks to Prof. Dr. Fugaku Aoki, Prof. Dr. Makoto Tachibana, 
Prof. Dr. Marjorie Brand, Prof. Dr. Michael R. Stallcup, Prof. Dr. Richard M. Schultz, Prof. 
Dr. Yoichi Shinkai for providing the cDNA contructs of histone H3.1, H3.2, G9a and 
HDAC2.  
For Prof. Dr. Wolfgang Fischle, I want to extend a sincere thanks to him for the 
helpful suggestions and the sharing of the experimental materials (peptides).   
For Prof. Dr. Robert.Schneider, I am really grateful to him for generously sharing his 
expertise concerning the histone variants and their deposition pathways into the chromatin. 
For Prof. Dr. Gert-Wieland Kohring, I offer my sincere gratitude to him for the 
permission to the use of the machines like French press and centrifuges. 
A special thanks is given to my supervising tutor, Dr. Konstantin Lepikhov (Kostya) 
for his great help with friendly kindness and endless patience from the beginning to the end of 
my PhD study covering the guidance of the hands-on experiments, the explanation of the 
principles, the suggestions of the solutions, the correction of the writing. He is very erudite 
and always the first one I ask for any suggestion or help. Besides work, I am very thankful to 
him in the daily life. It is never forgettable that he spent his precious time in helping me deal 
with my private things.     
Mrs. Nicole Jundel, to whom I am deeply indebted, is always giving me the most help 
as she could. Especially for the preparation of the bureaucratic materials and documents, it 
took her lots of time, sometimes even much more because of my mistakes. In the daily life, 
she is like a mother to me, always encouraging me and assisting me in solving the problems. 
For all the things she has done, my heart is overflowed with gratitude.   
Throughout my PhD work, Sarah Fuchs and Pascal Giehr, I owe them a lot for helping 
the performance of the experiments, analysis of the data, discussion of the results and so on. 
Apart from that, we spent a lot of wonderful time together, talking about many topics 
including movies, politics and so on, sharing the funny stories about football, traveling, 
festivals, etc. Especially Sarah, she is more than a friend to me. She is like my blood sister.  
Dr. Sascha Tierling, my best friend, to whom I can not find words to express my 
gratitude, is always offering his help both in my experiments and in my daily life. There are 
  
so many wonderful moments to remember, such as the visiting of the saarschleifer, the canoe 
day, the trip in the “Museumszug”, the relaxing time in the hiking tours, the Silvester-Parties 
with all his family members and so on, of which the Champion League Match between 
Bayern münchen and Schachtar Donezk is the most impressive. We are much alike in many 
aspects, from the hobby, the world views, philosophy to value. For me, he is also more than a 
friend. He is like my blood brother.  
I also want to express my warm thanks to Dr. Nicole Souren, Pavlo Lutsik and my 
alumni Priv. Doz. Dr. Martina Paulsen, Dr. Julia Arand and Dr. Mark Wossidlo for their good 
suggestions for my Ph study and the pleasant time together for dinner, playing poker and so 
on.    
Beate Schmitt, Jasmin Kirch, Christina Lo Porto and Victoria Weinhold, Eva Dilly, to 
whom I owe a great debt of gratitude, helped me in sequencing, mice breeding and so on.  
For Dr. Gilles Gasparoni, I am really grateful to him for his nice R course, from which 
I learned and benefit a lot for the future work.     
For Dr. Monika Frings, I wish to thank her for her useful Tips to inject the mice.  
I also consider it an honor to have Michael Glander as my colleague, who helped me 
several times in resolving the computer problems, for which I am really grateful. 
In addition, I am indebted to many of my colleagues and alumni, Dr. Nina Gasparoni, 
Diana Santacruz, Anna Tartakowski, Tatiana Guerrero Marçola, Tabea Trampert, 
Wachiraporn Wanichnopparat, Stefanie Geisen, Dr. Karl Nordström, Abdulrahman Salhab, 
Sam Ringle, Dirk Schumacher, for the surport and pleasant time in the lab or in Mensa.  
At the end, a special thanks to my parents, words cannot express how much gratitude I 
want to extend to my mother and father for all of the sacrifices that they have made during all 
these years. All the support and encouragement from my parents pushed me forward on the 
way to pursue my PhD degree. Meanwhile, I would like to express appreciation to my 
engaged wife, Ping Zhong, who is always giving me the full support and understanding in 
getting me through my PhD study, which made this dissertation possible. Her role in both my 
work and daily life was, is and will be so important that gratitude is always both inadequate 
and superfluous. 
  
Contents 
1 Introduction ........................................................................................................................... 1 
1.1 Epigenetic reprogramming in mammalian development ................................................. 1 
1.2 Dynamics of histone variants in mouse zygotes .............................................................. 1 
1.2.1 Histone H1 and its variants ....................................................................................... 2 
1.2.2 Histone H2A and its variants .................................................................................... 2 
1.2.3 Histone H2B and its variants ..................................................................................... 3 
1.2.4 Histone H3 and its variants ....................................................................................... 4 
1.2.5 Histone H4 and its variants ....................................................................................... 5 
1.3 Dynamics of histone modifications and related modifying enzymes in mouse zygotes .. 6 
1.3.1 Modifications on histone H1 ..................................................................................... 6 
1.3.2 Modifications on histone H2A .................................................................................. 6 
1.3.3 Modifications on histone H2B .................................................................................. 7 
1.3.4 Modifications on histone H3 ..................................................................................... 7 
1.3.5 Modificaitons on histone H4 ................................................................................... 10 
1.4 Dynamics of DNA modifications in mouse zygotes ...................................................... 12 
1.5 Cross talks between histone variants, histone modifications and DNA methylation in 
mouse zygotes ...................................................................................................................... 13 
1.6 Aims and objectives ....................................................................................................... 14 
2 Materials and Methods ....................................................................................................... 15 
2.1 Materials ......................................................................................................................... 15 
2.1.1 Mouse strains ........................................................................................................... 15 
2.1.2 Chemicals ................................................................................................................ 15 
2.1.3 Antibodies ............................................................................................................... 16 
2.1.4 Enzymes .................................................................................................................. 17 
2.1.5 Prokaryotic cells ...................................................................................................... 17 
2.1.6 Mediums .................................................................................................................. 17 
2.1.7 Solutions and buffers ............................................................................................... 18 
2.1.8 Primers .................................................................................................................... 18 
2.1.9 Reaction kits ............................................................................................................ 20 
2.1.10 Instruments ............................................................................................................ 20 
2.2 Methods .......................................................................................................................... 21 
2.2.1 Mouse superovulation and execution ...................................................................... 21 
2.2.2 RNA isolation .......................................................................................................... 21 
2.2.3 cDNA reverse transcription ..................................................................................... 21 
2.2.4 Polymerase chain reaction (PCR) ........................................................................... 21 
2.2.5 Plasmids preparation ............................................................................................... 21 
2.2.6 Site-specific mutagenesis ........................................................................................ 22 
2.2.7 Acetylation-mimetic mutant of H3.1 ...................................................................... 22 
2.2.8 In vitro transcription of mRNAs ............................................................................. 22 
2.2.9 Protein Purification ................................................................................................. 23 
2.2.10 Verification of H3K9me2 by Western blotting ..................................................... 23 
  
2.2.11 In vitro fertilization ............................................................................................... 23 
2.2.12 Embryo culture ...................................................................................................... 23 
2.2.13 Chaetocin treatment ............................................................................................... 23 
2.2.14 Cycloheximide treatment and Edu labelling ......................................................... 24 
2.2.15 Preparation of microinjection needles ................................................................... 24 
2.2.16 Microinjection of mRNAs or proteins into zygotes .............................................. 24 
2.2.17 Triton treatment of zygotes ................................................................................... 24 
2.2.18 Chromatin incorporation of histone H3 variants monitored by live imaging ....... 24 
2.2.19 Immunofluorescence staining ............................................................................... 24 
2.2.20 IF Microscopy, quantification and statistical analysis .......................................... 25 
2.2.21 Hairpin bisulfite sequencing .................................................................................. 25 
3 Results .................................................................................................................................. 26 
3.1 Effects of K9R mutation of H3.1/2/3 on modifications of both histone and DNA in 
mouse zygotes ...................................................................................................................... 26 
3.1.1 Dynamic pattern of H3K9me2 through DNA replication ....................................... 26 
3.1.2 Dynamic pattern of H3K9me3 through DNA replication ....................................... 26 
3.1.3 Dynamic pattern of H3K9ac through DNA replication .......................................... 27 
3.1.4 Nuclear localization and chromatin incorporation of H3.1/2/3-GFPWTs and K9R 
mutants ............................................................................................................................. 27 
3.1.5 Effects of H3.1/2/3-GFPK9R on H3K9me2 ........................................................... 29 
3.1.6 Effects of H3.1/2/3-GFPK9R on H3K9me3 ........................................................... 30 
3.1.7 Effects of H3.1/2/3-GFPK9R on H3K9ac ............................................................... 31 
3.1.8 Effects of H3.1/2/3-GFPK9R on 5mC and 5hmC ................................................... 32 
3.2 Effects of S10A and T11A mutations of H3.1/2/3-GFP on modifications of both histone 
and DNA in mouse zygotes .................................................................................................. 33 
3.2.1 Dynamic patterns of H3S10phos and H3T11phos throughout the mouse zygotic 
stage .................................................................................................................................. 34 
3.2.2 Effects of H3.1/2/3-GFPS10A on H3K9me2, 5mC and 5hmC .............................. 34 
3.2.3 Effects of H3.1/2/3-GFPT11A on H3T11phos, H3K9me2, 5mC and 5hmC ......... 36 
3.3 Introduction of H3K9me2 into the paternal chromatin of mouse zygotes by G9aFL-GFP 
and G9aCat-NLS-GFP ......................................................................................................... 41 
3.3.1 Effects on H3K9me2 ............................................................................................... 41 
3.3.2 Effects on 5mC and 5hmC ...................................................................................... 43 
3.4 Dissecting relations between H3K9me2 and histone H3.1/2/3 by co-injection of 
G9aCat-NLS-GFP and H3.1/2/3-GFPT11A ........................................................................ 45 
3.4.1 Effects on H3K9me2 ............................................................................................... 45 
3.5 Microinjection of H3.3-GFPK9me2 proteins ................................................................. 46 
3.5.1 Localization of purified proteins of H3.3-GFPK9me2 ........................................... 46 
3.6 Relation between H3K9ac and DNA methylation ......................................................... 48 
3.6.1 Effect on DNA methylation by loss of H3K9ac ..................................................... 48 
3.6.2 Effect on H3K9me2 by co-injection of G9aCat-NLS-GFP and HDAC1-GFP ...... 50 
4 Discussion ............................................................................................................................. 51 
  
4.1 Inefficient disruption in H3K9me2/me3/ac by H3.1/2/3-GFPK9R in both parental 
genomes of mouse zygotes ................................................................................................... 51 
4.2 Phosphorylation on H3.1/2S10 and H3.1/2T11 serving as a double switch for H3K9me2 
in the maternal genome of mouse zygotes ........................................................................... 53 
4.3 Artificial introduction of H3K9me2 on H3.1 and H3.2 fails to block global active DNA 
demethylation in the paternal genome of mouse zygotes..................................................... 55 
4.4 Relation between H3.3 and active DNA demethylation in both parental genomes of 
mouse zygotes ...................................................................................................................... 57 
4.5 Conclusions .................................................................................................................... 58 
4.6 Perspectives .................................................................................................................... 59 
Zusammenfassung .................................................................................................................. 60 
Summary ................................................................................................................................. 61 
References ............................................................................................................................... 62 
Appendices .............................................................................................................................. 75 
Abbreviations .......................................................................................................................... 78 
Curriculum Vitae ................................................................................................................... 80 
  
 
 
 
Introduction 
 
1 
 
1 Introduction 
1.1 Epigenetic reprogramming in mammalian development 
After experiencing a stage of being buried for more than one century when the “Lamarckian 
inheritance” was proposed and another period of being silenced for half a century when the 
term “epigenetics” was first coined by Conrad Waddington in the early 1940s (Waddington, 
1942), as a new subject, “epigenetics” has been extensively and substantially studied from the 
late 1990s on. Notably, the current concept of epigenetics has been narrowed to some extent 
from its original definition with the rapid development of genetics over the past decades, with 
its general acceptance as changes in phenotype without changes in genotype. More accurately 
speaking, on the molecular level, epigenetics involves the modifications occurring on DNA, 
RNA or histones which are inherited mitotically and/or meiotically from the parent cells to 
the daughter cells and could decisively determine the gene functions or expressions without 
the changes to the underlying DNA sequence itself (Wu and Morris, 2001). In 1997, as a 
hallmark event in the cloning history, the birth of “Dolly” greatly boosted the interests in 
epigenetic reprogramming in mammalian embryos (Wilmut et al., 1997), which suggested the 
great powerful ability of a mammalian oocyte to reprogram a differentiated somatic cell into a 
totipotent status. Naturally, the formation of a mammalian zygotes is created by the fusion of 
an oocyte with a spermatozoon, which immediately triggers the epigenetic reprogramming of 
both highly differentiated gametes involving replacement of protamines with histone variants, 
dynamic changes of histone modifications, iterative oxidation of 5mC possibly followed by 
DNA repair-related pathways, RNA-mediated regulation as well as interactions among them 
and so forth, comprising and displaying rather complicated and multiple regulation layers 
essential for normal embryo development. For mice, it is rather significant in the zygotic 
stage, for it is preparing for the zygotic genome activation occurring at the 2-cell stage and its 
epigenetic dysregulation could cause embryo development failure. Therefore, the dissection 
of the roles of histone modifications and DNA methylation in mouse zygotic stage is really 
helpful for a better understanding of epigenetic reprogramming in embryo development, 
which will shed a light on reprogramming in stem cells, induced pluripotent cells as well as 
somatic cell nuclear cloning. 
1.2 Dynamics of histone variants in mouse zygotes 
Two copies each of the core histones H2A, H2B, H3, and H4, together with approximately 
146 base pairs of DNA, form a nucleosome, the basic repeating unit for eukaryotic chromatin 
(Luger et al., 1997). Between the two adjacent nucleosomes, histone H1 is located, which 
could facilitate the packaging of DNA into the octamer of core histones. Upon fertilization, 
the replacement of the protamines in sperm with maternally-derived histones and their 
variants in oocytes causes a decondensation structure in the paternal genome during the 
formation of pronuclei. Soon after entering into the replication phase, there is another wave of 
histone incorporation in both pronuclei in zygotes, which is dependent on DNA synthesis. 
Notably, histone chaperones also participate in both processes so as to ensure that all the 
histone variants are deposited into the proper regions. In general, histones could fall into two 
groups, canonical and non-canonical histones, which differ in their primary structure, as well 
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as in the organization of their genes (intron-less) and mRNAs (Marzluff et al., 2002; Marzluff 
et al., 2008).  
1.2.1 Histone H1 and its variants 
Histone H1 is defined as a linker histone, which consists of three different regions, that is, a 
short C-terminal tail of around 35 amino acids, a central globular domain with roughly 80 
amino acids long and a rather long N-terminal tail of approximately 100 amino acids 
(Hartman et al., 1977). It is located between the adjacent nucleosomes, binds to the 
nucleosome where the DNA enters or exits and protects the linker DNA via its evolutionarily 
conserved globular domain, and facilitates to stabilize the formation of higher-order 
chromatin structures by its two highly variable flanking terminal tails (Allan et al., 1980; 
Harshman et al., 2013; Zhou et al., 2013). In mice, there are at least 9 members of histone H1 
family have been identified in mice so far, including five somatic subtypes H1a, H1b, H1c, 
H1d and H1e, one testis-specific linker histone H1t, one differentiation-specific linker histone 
H1
0
 as well as another two isoforms of oocyte-specific linker histone H1FOO (formerly 
H1OO), namely H1FOO α and β. The variety of H1 isoforms is summarized in Fig. 1.1 
(Lennox and Cohen, 1983; Lennox and Cohen, 1984; Seyedin and Kistler, 1979; Tanaka et 
al., 2005). Apart from H1
0
 and H1FOO, the others follow a replication dependent way 
(Marzluff et al., 2002). Notably, oocyte-specific linker histone H1FOO appears in both 
pronuclei during 1-cell stage, decreases in the nuclei at 2-cell stage and becomes undetectable 
after 4-cell stage (Gao et al., 2004), with H1FOO α isoform being much more abundant than 
the β one in the zygotes (Tanaka et al., 2005). The somatic variants are absent throughout 
oogenesis up to 1-cell stage and become detectable from 2-cell-stage on (Gao et al., 2004). 
However, an opposite observation has been reported that the depositions of somatic variants 
into the chromatin occur as soon as the formation of the pronuclei after fertilization (Adenot 
et al., 2000). The discrepancy could be resulted from the specificities of the antibodies. As for 
the differentiation-specific linker histone H1
0
, it has been proved that H1
0
 knockout mice 
have a normal development, suggesting that it is indispensable for mouse embryogenesis 
(Sirotkin et al., 1995).  
 
Fig. 1.1 The schematic overview of mouse histone H1 variants 
1.2.2 Histone H2A and its variants  
Among the core histones, the canonical H2A harbors a rather extended family, including H2A 
isoforms, H2A.X, H2A.Z isoforms, H2A.B subtypes as well as macroH2A subtypes, with N-
terminal tails and fold domains being relatively conserved and C-terminal tails being rather 
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divergent (Costanzi and Pehrson, 2001; Govin et al., 2007; Marzluff et al., 2002; Matsuda et 
al., 2010; Rasmussen et al., 1999; West and Bonner, 1980), which are summarized in Fig. 1.2. 
Although many isoforms of H2A in mouse have been identified, no reports concerning the 
site variation related functions have emerged. In mouse zygotes, one of the isoforms of H2A 
has been described to be rather lowly abundant after fertilization till 4-cell stage (Nashun et 
al., 2010), which is in line with the expression data (Kafer et al., 2008). In contrast, H2A.X is 
highly expressed throughout the preimplantation stage (Nashun et al., 2010). Particularly in 
zygotic period, H2A.X reaches the signal peak and shows equal distribution in both pronuclei. 
However, H2A.X is nonessential for mouse embryo development, for the H2A.X−/− mice are 
viable, although pleiotropic effects are rather obvious in chromosomal instability, repair 
defects and so forth (Celeste et al., 2002). Another variant, H2A.Z, although it is highly 
incorporated in the chromatin of GV and MII oocytes, is gradually evicted from the maternal 
genome from the beginning of fertilization to 6 hours post fertilization (hpf) and reappeared 
into the nuclei in the morula stage (Nashun et al., 2010). Inconsistent with the observation, 
Ana Bošković et al reported the presence of H2A.Z as early as the late 2-cell stage by using 
the freshly flushed embryos (Boskovic et al., 2012), which may explain the discrepancy 
between these two experiments. Indeed, the H2A.Z−/− knockout embryos have shown the 
normal formation of blastocyst, although the severe defects emerge shortly after implantation 
(Faast et al., 2001). As for H2A.B and its subtypes, they express in a tissue-specific manner, 
strongly in testis and less abundantly in brain (Chadwick and Willard, 2001; Ishibashi et al., 
2010; Soboleva et al., 2012). Furthermore, Wu et al. have reported that its subtypes, 
H2ALap2 and Lap3, which are strongly detected in sperms, become undetectable by being 
excluded from the paternal pericentric heterochromatin regions after sperm-egg fusion (Wu et 
al., 2008). As the largest member in this family, macroH2A, which is structurally rather 
diverse in its C-terminal tail containing a nonhistone domain (NHD) (Pehrson and Fried, 
1992), is abundantly present in the form of mH2A1.2 in chromatin of MII oocytes while 
absent in the sperm during fertilization, begins to be progressively stripped from the maternal 
genome upon fertilization and becomes undetectable from PN3 stage on until reaching the 
morula stage (Chang et al., 2005; Nashun et al., 2010). However, the biological meanings of 
the transient asymmetry and the lost of macroH2A are still unknown. 
1.2.3 Histone H2B and its variants  
Together with H2A, H2B forms a heterotypic dimer and is relatively less diverse than its 
partner. Thus far, 14 variants of H2B have been reported, namely 11 canonical isoforms and 3 
testis-specific subtypes (Fig. 1.3). The canonical ones are constantly appearing in the nuclei 
during the preimplantation development, while the noncanonical ones play yet unknown roles 
in spermatogenesis (Govin et al., 2007; Kamakaka and Biggins, 2005; Marzluff et al., 2002; 
Nashun et al., 2010). Notably, H2BL1 may be involved during the protamine-histone 
exchange soon after fertilization, for it has been detected in mature sperms at a certain amount 
(Govin et al., 2007).   
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Fig. 1.2 The schematic overview of mouse histone H2A variants 
 
Fig. 1.3 The schematic overview of mouse histone H2B variants 
1.2.4 Histone H3 and its variants  
In mice, structurally, histone H3 variants could fall into two subgroups. One subgroup 
consists of H3.1, H3.2 and H3.3, which have the same size but differ from one another by 
only five amino acids (Loyola and Almouzni, 2007). And another subgroup encompasses 
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CENP-A isoforms produced by different splicing, which differentiate either in the N-terminus 
or in the C-terminal histone fold domain (Craig et al., 1999; Marzluff et al., 2002; Van Hooser 
et al., 1999). The currently identified histone H3 variants are exhibited in Fig. 1.4. Although a 
testis-specific histone H3 variant (H3t) in human has been isolated and purified (Tachiwana et 
al., 2008), the counterpart in mice has still not been found so far. During the zygotic stage, the 
immunostaining using the H3.1/2-specific antibody has shown that both canonical histones 
are only confined to the maternal chromatin in G1 phase, begin to incorporate into both 
pronuclei at the commencement of S phase and remain like this through G2 phase (van der 
Heijden et al., 2005). Likewise, with eGFP being tagged in the C-terminus, H3.1 is observed 
to deposit into both male and female chromatins in a replication-dependent manner 
(Santenard et al., 2010). Similar to H3.1-eGFP, Flag-H3.2 also shows an equal distribution 
between both pronuclei during replication phase (Akiyama et al., 2011). Nevertheless, the 
ability of H3.1 to localize into the pronuclei is abolished when the Flag or eGFP is fused to its 
N-terminus (Akiyama et al., 2011), implying the importance of proper fusion strategy for 
histones possibly in a variant-specific manner. As a noncanonical histone variant, H3.3 is 
preferentially located in the male pronuclues after fertilization up to replication phase. It starts 
to appear in the female chromatin concomitant with replication. Later, it is equivalent in both 
pronuclei when G2 phase is reached. The dynamic pattern of H3.3 is consistent with that of its 
specific chaperon, Hira (Inoue and Zhang, 2014; van der Heijden et al., 2005). It has been 
demonstrate that H3.3 is indispensable for the formation of the paternal pronuclues (Inoue and 
Zhang, 2014), while the absence of H3.1 and H3.2 has a severe effect on blastocyst formation 
(Akiyama et al., 2011). CENP-A is another variant in the histone H3 family and plays a rather 
critical role in the post-implantation stages, because no CENP-A null mice could be obtained 
beyond 6.5 days postconception (Howman et al., 2000). The distribution patterns of histone 
H3 variants in mouse zygotes are schematically illustrated in Fig. 1.5.  
 
Fig. 1.4 The schematic overview of mouse histone H3 variants 
1.2.5 Histone H4 and its variants  
Evolutionarily, H4 is rather conserved, although it is encoded by multiple genes, for no non-
allelic variants have been discovered so far and even the isoforms which could be derived 
from the alternative splicing are not found (Kamakaka and Biggins, 2005). In mice, H4 shares 
the same dynamic pattern with H3.3 in zygotic stage (Akiyama et al., 2011; Inoue and Zhang, 
2014), since they could bind with each other to form a heterotypic dimer and later a tetramer. 
In Fig. 1.5, the distribution patterns of the main histone variants are summarized.  
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Fig. 1.5 The schematic of distribution patterns of histones in mouse zygotes 
1.3 Dynamics of histone modifications and related modifying 
enzymes in mouse zygotes 
Histone posttranscriptional modifications function in a wide variety of biological processes, 
for instance, DNA repair, gene regulation and chromosome condensation (Cosgrove et al., 
2004; Zhou et al., 2011). Typically, these marks are performed via addition or removal of 
chemical attachments, such as acetyl, methyl, phosphate, polypeptide ubiquitin and so forth to 
multiple targeting sites including lysine, arginine, serine, threonine and so on. This occurs 
mostly within the histone N-terminal tails protruding from the nucleosome body as well as on 
the histone fold domains by the histone modifying enzymes either before or after histone 
incorporation into the chromatin. In mouse zygotes, the patterns of histone modifications in 
both pronuclei are rather dynamic and many of them still have to be characterized.   
1.3.1 Modifications on histone H1  
Currently, multiple modifications on several sites of Histone H1 have been identified in 
different species. These modifications include phosphorylation, methylation, acetylation and 
so forth (Harshman et al., 2013; Villar-Garea and Imhof, 2008). Note that the related writers 
for these modifications have redundant activities, for example Aurora B kinase (Daujat et al., 
2005; Hergeth et al., 2011), G9a/KMT1C (Weiss et al., 2010) and GCN5 (Kamieniarz et al., 
2012) modify histone H1 but are also responsible for H3S10phos, H3K9me2, H3K9ac/ 
H3K14ac, respectively. However, their dynamics in mouse zygotes are yet to be described.  
1.3.2 Modifications on histone H2A 
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The well-studied modification on the H2A variant, H2A.X, is the phosphorylation on 
serine139 in its C-terminal, also called gamma H2A.X. It responds to DNA double strand 
breaks (DSBs) and serves as a sensor for the assembly of DNA repair proteins at the damaged 
sites. In mouse zygotes, it shows the preferential localization in the paternal pronucleus 
(Wossidlo et al., 2010; Ziegler-Birling et al., 2009). Even if the zygotes are exposed to DNA 
damaging agents, still much more γH2A.X foci are observed in the male genome than in the 
female one, from which the authors have concluded that female chromatin has a much more 
proficient capacity in DNA repair (Derijck et al., 2006). Another described modification in 
mouse zygotes is the acetylation at K4+K7+ K11 of H2A.Z, which is at detectable level but 
rather weak from PN0 to PN3 in both pronuclei, and then becomes undetectable up to 2-cell 
stage (Boskovic et al., 2012). Apart from the marks above, the N-terminal part of human 
canonical H2A could also be phosphorylated, acetylated and methylated at the sites of S1, K3 
as well as K5 and K9, respectively (Ancelin et al., 2006; Wyrick and Parra, 2009; Zhang et 
al., 2004). So far, on H2A, only the pattern of K5ac has been shown in mouse zygotes, 
namely equal distribution in both pronuclei (Stein et al., 1997) and those of the other marks in 
mouse embryos are still lacking. The other modifications like ubiquitination on H2A or 
H2A.Z are also worth considering in mouse zygotes, for they could establish the cross talk 
with H3K4me2/3 or H3S10phos, and influence the histone replacement (Joo et al., 2007; 
Nakagawa et al., 2008; Sarcinella et al., 2007; Weake and Workman, 2008).    
1.3.3 Modifications on histone H2B  
Based on the literature, profiles of few modifications on histone H2B in mouse zygotes are 
available till now. Only general acetylation on H2B using an unspecific antibody has been 
described to be located throughout both pronuclei uniformly in mouse zygotes (Stein et al., 
1997). However, acetylation on K5, K12, K15 and K20, phosphorylation on S14 and S36, 
methylation on K30 and K34 have been reported in human, bovine, chicken and so on 
(Kurdistani et al., 2004; Zhang and Tang, 2003; Zhang et al., 2003). Due to the rather 
conserved sequences across the species, how these modifications change and whether they 
play any roles or not in mouse embryo development should be addressed in the future.      
1.3.4 Modifications on histone H3  
In mouse embryos, the modifications of lysine and serine residues on the N-terminal tail of 
histone H3 have been very intensively investigated, including monomethylation (me1), 
dimethylaition (me2), trimethylation (me3), acetylation (ac) as well as phosphorylation 
(phos). Methylation on lysine 4 is typically regarded as an active mark for gene transcription 
(Barski et al., 2007; Bernstein et al., 2007; Guenther et al., 2007), although there are recent 
evidences which indicate that it could indicate the repressive state in some cases (Cheng et al., 
2014; Margaritis et al., 2012). For H3K4me1, it appears only in the maternal genome upon 
fertilization, becomes detectable in both parental genomes after the formation of pronuclei 
with showing more abundantly in the maternal one and displays equal signal intensities in 
PN4/5 stage, while H3K4me2 and me3 are undetectable from the male side up to late PN3, 
begin to emerge into male pronucleus at around PN4 and reach comparable distribution in 
both pronuclei at PN5 (Lepikhov and Walter, 2004; Santenard et al., 2010; van der Heijden et 
al., 2005). The meaning behind the delayed setting of H3K4me2/3 is still mysterious. 
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However, rather intriguingly, two groups reported that asymmetric di-methylation of histone 
H3 arginine 2 (H3R2me2a) is mutually antagonistic to H3K4me2/3 in human cells and 
budding yeast, respectively (Guccione et al., 2007; Kirmizis et al., 2007). Furthermore, based 
on Chip-sequencing data, two groups have claimed that it is H3R2 symmetric dimethylation 
(H3R2me2s) that is highly correlated with H3K4me3 on the genome wide scale in mice 
(Migliori et al., 2012; Yuan et al., 2012). Besides this, H3T6phos may also be involved in 
regulation of deposition of methyl group on lysine4 due to the observation that ablation of 
H3T6phos strongly enhances the demethylation on lysine 4 (Metzger et al., 2010). Together, 
they strongly imply a possible coordination mechanism in mouse zygotes which should be 
tested in the near future. Another neighboring site, threonine 3, once being phosphorylated, is 
essential for the activation of Aurora B, despite in Xenopus eggs (Zierhut et al., 2014), 
pointing out that H3T3phos could serve as a upstream switch for H3S10phos, the well-known 
target for Aurora B. Using the specific antibodies to trace H3K9 methylation patterns, it 
shows that H3K9me1 is positive in both genomes throughout the zygotic stage, which is the 
same for H3K9ac, whereas both H3K9me2 and H3K9me3 are regarded negative in male 
pronucleus, in which, notably, H3K9me2 is gradually placed during replication at a rather low 
but detectable level (Arney et al., 2002; Lepikhov and Walter, 2004; Santenard et al., 2010; 
Santos et al., 2005; Stein et al., 1997; van der Heijden et al., 2005). Its neighboring 
modification, H3S10phos, displays the following dynamic pattern: it disappeares from G1 
stage on, becomes almost invisible during replication, and appears de novo in G2 stage. 
However, the different commercial antibodies against H3S10phos perform differently in 
immunostaining, that is, completely absent or still detectable to some degree during 
replication in different experiments from two independent research groups, respectively 
(Ribeiro-Mason et al., 2012; Teperek-Tkacz et al., 2010). As a typical case for crosstalk on 
histone 3, phosphorylation at serine 10, together with methylation on K9, could serve as a 
critical “switch” on the transcription according to the barcode hypothesis (Strahl and Allis, 
2000), which is supported by some evidence (Lo et al., 2001; Ng et al., 2007). For 
phosphorylation at threonine 11, no reports about its dynamics are available. Because 
phosphorylation on either serine 10 or threonine 11 could influence H3K9ac in somatic cells 
(Dinant et al., 2008; Metzger et al., 2008), whether this effect exists in mouse zygotes or not 
should be investigated. Also, similar effect might be applied to H3K14ac, because it follows 
the same pattern as H3K9ac and could also be introduced by the histone acetyltransferase, 
GCN5 (Cheung et al., 2000; Kim et al., 2003; Lo et al., 2000). The in vitro data on 
interactions among the modifications on these four sites, K9, S10, T11 and K14, have 
provided some hints that pre-acteylation of K9 regulates phosphorylation of S10 in a positive 
manner while pre-acetylation of K14 causes a negative effect on phosphorylation of S10, but 
not vice verse for these two cases (Cheung et al., 2000; Lo et al., 2000). In addition, a 
decrease of H3S10phos is observed when H3T11 phos pre-exists (Demidov et al., 2009), 
consistent with the observation from another group that they are mutually exclusive (Liokatis 
et al., 2012). The same observation is obtained for the crosstalk (mutually exclusive) between 
H3S10phos and H3T6phos (Liokatis et al., 2012). The other modifications on neighboring 
sites, like H3R17me2, H3K18ac and H3K23ac, show uniform distribution in both pronuclei 
in mouse zygotes (Sarmento et al., 2004; Stein et al., 1997; van der Heijden et al., 2005). 
Different methylation grades of H3K27 show rather similar patterns to H3K4 methylation. 
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Briefly, H3K27me1 is observed in both pronuclei with stronger staining in female one 
throughout the PN stages. For H3K27me2 and me3, they are beyond detection in the paternal 
pronucleus during the early PN stages and become increasingly accumulated until comparable 
to those in the maternal one in the late PN stages (Santenard et al., 2010; Santos et al., 2005). 
Furthermore, Santenard et al. have provided the evidence that H3.3K27 is critical for 
heterochromatin formation in mouse zygotes (Santenard et al., 2010). Another form of K27 
modification is acetylation, which appears to be opposite to H3K27me3, namely no H3K27ac 
in the maternal genome in the PN1-2 stages and getting appeared in both genomes in late 
stages (Hayashi-Takanaka et al., 2011; Santenard et al., 2010). The adjacent amino acid, 
serine 28, exists in the form of phosphorylation from the metaphase to telophase upon 
fertilization, and then undergoes dephosphorylation (van der Heijden et al., 2005). Its 
dynamics in the later stages remains elusive. The questions that to what extent H3S28phos 
could crosstalk with H3K27me (1/2/3) and whether H3S28phos could be responsible for the 
absence of H3K27me2/3 in the PN1-2 stages should be interrogated in mouse zygotes. For 
serine 31, which is specific to H3.3, could experience phosphorylation in the metaphase of 
mitosis, which could lead to target gene transcription (Hake et al., 2005), suggesting that 
H3.3S31phos might play a role in the metaphase of the first cell cycle of mouse embryo and 
prepare for the major zygotic genome activation (ZGA). For lysine 36, its trimethylated form 
has been reported to be located only in the maternal genome in mouse zygotes (Boskovic et 
al., 2012), although it serves as an active mark distributing in gene bodies (Butler and Dent, 
2012; Wagner and Carpenter, 2012), which may potentially establish a crosstalk with 
H3K27me2/3, as reported by Yuan et al (Yuan et al., 2011). Based on the data above, we 
could speculate that H3K36me2 may follow the same pattern as H3K36me3. Intriguingly, 
H3K36me2 has been confirmed to be associated with H3.3 but not H3.1 in mouse embryos 
(Lin et al., 2013). These observations raise the question: why H3K36 methylation is absent 
from the paternal genome even if H3.3 is preferentially deposited into the male pronucleus. 
Like other lysine sites, K36 could also be modified by an acetyl group via the histone 
acetyltransferases, such as GCN5. And H3K36ac has been found to be predominantly mapped 
to the promoters of RNA polymerase II-transcribed genes in yeast (Morris et al., 2007). 
However, the pattern of H3K36ac has not been defined yet in mouse embryos. For K56 on 
H3, it is located at the entry–exit point of the DNA on the nucleosome. Its acetylation could 
respond to DNA repair (Vempati et al., 2010; Yuan et al., 2009), which may contribute to 
active DNA demthylation in the paternal genome of mouse zygotes, because BER or NER 
have been suggested to be involved in active DNA demthylation (Santos et al., 2013; 
Wossidlo et al., 2010). As a novel identified histone mark, H3K56me3 is found to be enriched 
in the pericentromeres and plays a role in heterochromatin formation, together with H3K9me3 
(Jack et al., 2013), probably showing the similar pattern to H3K9me3 in mouse zygotes. 
Recently, H3K64me3 has been described to have the preferential localization in the maternal 
genome in mouse zygotes (Daujat et al., 2009),  which is dependent on H3K9me3 (Lange et 
al., 2013). However, its counterpart, H3K64ac, serves as an active mark for gene transcription 
(Di Cerbo et al., 2014), about which the data are still unknown in mouse embryos to our 
knowledge. Apart from modifications on the tail of histone H3, the other marks residing in the 
folding domain could also be of interest, such as H3K79 methylation, which is rather 
abundantly enriched in the chromosomes in MII oocytes. Nevertheless, demethylation takes 
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place immediately after fertilization on lysine 79, causing an unmethylated status throughout 
the zygotic stage (Ooga et al., 2008), which may be occupied by an acetyl group after that. In 
general, the crosstalks between different modifications are rather more complicated than 
expected due to the existence of distinct histone variants.    
1.3.5 Modificaitons on histone H4  
In mouse zygotes, hyperacetylation of histone H4 is strongly associated with male and weakly 
with female chromatin upon the entry of sperm into the MII oocytes. From the paternal side, 
acetylations at lysine 8 and 12 are inherited from the sperm, while the maternal chromatin is 
largely de-acetylated in mature MII oocyte (van der Heijden et al., 2006). Later, equivalent 
acetylation levels are observed in both pronuclei in advanced PN stages (Sarmento et al., 
2004). Similar results have been obtained by using the antibody specific for acetylation at 
lysine 5 on histone H4, showing asymmetric pattern throughout the G1 phase and symmetric 
one during S and G2 phases (Adenot et al., 1997). In parallel, Sarmento et al. evaluate histone 
H4 arginine 3 methylation (H2A/4R3me2) in the zygotic stage, which shows no or rather 
weak signals (Sarmento et al., 2004). Another studied site on histone H4 is lysine 20, on 
which mono, di and tri methyl groups could be added. In mouse zygotes, H4K20me1 is 
already detectable in both chromatins immediately after sperm-oocyte fusion, while 
H4K20me2 is at undetectable level in both pronuclei throughout the zygotic stage and 
H4K20me3 is only present in the perinucleolar ring in the female pronucleus (Kourmouli et 
al., 2004; Probst et al., 2007; van der Heijden et al., 2005; Wongtawan et al., 2011). The 
pattern of H4K20me3 resembles that of H3K9me3, which supports the observation that both 
these two marks are highly associated with heterochromatin formation (Burton and Torres-
Padilla, 2010). The dynamic profiles of different histone modifications in mouse zyogtes are 
summarized in the Fig. 1.6.  
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Fig. 1.6 The schematic illustration of histone modifications dynamics in mouse zygotes 
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1.4 Dynamics of DNA modifications in mouse zygotes 
DNA methylation is a modification where a methyl group (CH3) is covalently added to the 5-
carbon of the cytosine ring, which is referred to as 5-methylcytosine (5mC). Recently, with 
the discovery of ten-eleven translocation (TET) family enzymes, the oxidized forms of 5mC 
are sequentially identified, namely 5-Hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) 
and 5-carboxylcytosine (5caC), which are regarded as the new 6th, 7th and 8th bases of the 
mammalian genome, respectively (He et al., 2011; Ito et al., 2011; Tahiliani et al., 2009). 
Around one decade ago, the phenomenon that active DNA demethylation takes place 
preferentially in the paternal genome prior to DNA replication in mouse zygotes was 
described (Mayer et al., 2000; Oswald et al., 2000). In 2011, several groups demonstrated that 
5hmC is accumulated preferentially in the paternal genome, which is catalyzed by Tet3 
enzyme from 5mC in mouse zygotes (Gu et al., 2011; Iqbal et al., 2011; Wossidlo et al., 
2011), pointing out that oxidation of 5mC is at least one of the major upstream pathway for 
DNA demethylation. Later, Santos et al. proved that Tet3-based oxidation is confined to the 
time window of DNA replication (Santos et al., 2013). By generation of antibodies specific 
for 5fC and 5caC, Inoue et al. have provided the dynamic patterns of 5fC and 5caC in mouse 
zygotes, similar to 5hmC (Inoue et al., 2011). Based on the immunostaining, all the oxidized 
forms are diluted in a replication-dependent manner during the later cleavage stages (Inoue et 
al., 2011). The TDG-mediated pathway which is potentially very efficient for removal of 5fC 
and 5caC is somehow limited in mouse zygotes, for no influences on these two bases have 
been observed in TDG-knockout mice (Guo et al., 2014a), probably due to the regulatory 
mechanism that TDG could be inactivated by acetylation at 4 lysine sites in the N-terminal 
part shown recently by the in vitro data (Madabushi et al., 2013). Obviously, the other 
possible pathways, like deamination of 5mC to thymine, followed by Tets-mediated 
oxidization of thymine to 5-hydroxymethyluracil, or processed by DNA base excision repair 
in the final step, seem to be responsible for active DNA demethylation (Pfaffeneder et al., 
2014; Santos et al., 2013; Wossidlo et al., 2010). Except the active pathway, DNA 
demethylation could also be managed in a replication-dependent manner, which is assumed to 
be resulted from the absence of DNMT1. However, whether it is due to the missing of 
DNMT1 or other essential factors should be further investigated. Very recently, a very 
interesting result has been reported by three different groups that both active and passive 
DNA demethylation occur to distinct extents in parental genomes in mouse zygotes (Arand et 
al., 2015; Guo et al., 2014b; Shen et al., 2014), suggesting that the discrepancy in DNA 
demethylation between male and female pronuclei may be caused by the chromatin 
modifications and configuration. The dynamic patterns of 5mC and its oxidized forms in 
mouse zygotes are shown in Fig. 1.7.       
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Fig. 1.7 The schematic of dynamics of DNA modifications in mouse zygotes  
1.5 Cross talks between histone variants, histone modifications and 
DNA methylation in mouse zygotes 
In mouse zygotes, reprogramming involves chromatin reorganization and DNA demethylation 
(Mayer et al., 2000; Oswald et al., 2000; Santos et al., 2005). The crosstalk between these two 
cases has been being investigated for years. Globally, H3K9 methylation (me2 or me3) has 
been shown to be associated with DNA methylation across the species, such as Neurospora 
crassa (Tamaru and Selker, 2001), Arabidopsis thaliana (Bernatavichute et al., 2008; Jackson 
et al., 2004; Jackson et al., 2002) and mice (Lehnertz et al., 2003), although Soppe et al. have 
shown the opposite results in Arabidopsis thaliana (Soppe et al., 2002). Indeed, it has been 
reported recently that in mouse zygotes, H3K9me2 attracts PGC7 and together they protect 
against DNA demethylation in the maternal genome as well as some loci in the paternal one 
(Nakamura et al., 2007; Nakamura et al., 2012). As the potential carriers for H3K9me2 as 
well as other modifications, histone H3 variants H3.1, H3.2, and H3.3, play a role in 
separating the chromatin into different functional compartments and are targets for distinct 
posttranslational "signatures" (Hake and Allis, 2006). Although we know that H3.1 and H3.2 
are reported to be equally deposited into both pronuclei during replication and that H3.3 is 
preferentially incorporated into the replicating paternal pronucleus before and during 
replication (Akiyama et al., 2011; Torres-Padilla et al., 2006; van der Heijden et al., 2005), so 
far no data available about the relation between the dynamics of histone H3 variants, the 
deposition of H3K9me2 and DNA methylation in mouse zygotes. Hence, the dissection of the 
raltions among these three players would definitely give us a deeper insight in chromatin 
reorganization and DNA demethylation. Additionally, whether histone modifications at other 
lysine residues contribute to DNA methylation or demethylations - this issue has to be 
addressed in the nearest future. For example, unmethylated histone 3 at lysine 4 could be well 
recognized by DNMT3A–DNMT3L complex both in vivo and in vitro, respectively, which 
further leads to de novo methylation (Hashimoto et al., 2010; Hu et al., 2009; Ooi et al., 2007; 
Otani et al., 2009; Zhang et al., 2010). Moreover, genome-wide mapping of DNA methylation 
and H3K27 trimethylation in mouse embryonic stem cells shows that a certain portion of 
repressed genes encompass these two marks in parallel (Fouse et al., 2008), indicating that 
H3K27me3 may be the protector for 5mC in some local regions in mouse zygotes. 
Additionally, H3K36me3 is observed to appear asymmetrically only in the maternal 
pronucleus (Boskovic et al., 2012). Combined with the recently published data indicating that 
Dnmt3a, which has been shown the localization in both pronuclei (Gu et al., 2011; Hirasawa 
Introduction 
 
14 
 
et al., 2008), recognizes H3K36me3 and triggers de novo DNA methylation in vitro 
(Dhayalan et al., 2010), it is tempting to speculate the potential mechanistic link between 
H3K36me3 and de novo methylation in mouse zygotes. As for histone variants, they add 
another layer of complexity for regulation of modifications on either histones or DNA, among 
which H3.3 is the most studied one in mouse zygotes. By knocking down of either H3.3 or its 
chaperone Hira, the formation of the paternal pronucleus is completely abolished due to the 
inability to form functional nucleosomes (Inoue and Zhang, 2014). Furthermore, site mutation 
experiment of H3.3 at lysine 27 to arginine has shown that heterochromatin formation of 
pericentromeric domains could be greatly disrupted in 2-cell mouse embryos. Unfortunately, 
no data about DNA methylation have been displayed in this publication (Santenard et al., 
2010). Another interesting player is H2A.Z. In other species, like Arabidopsis thaliana and 
human cells, it has been shown that H2A.Z is mutually exclusive with DNA methylation and 
facilitates DNA repair pathway by creating a relatively open chromatin (Xu et al., 2012; 
Zilberman et al., 2008). Notably, the deposition of H2A.Z has been demonstrated to be 
regulated by H3K56 acetylation (Watanabe et al., 2013). It still remains to be investigated that 
to what extent the role of H2A.Z in mouse zygotes is evolutionarily conserved. Taken 
together, histone variants are important players in chromatin reorganization and DNA 
demethylation in mammalian zygotes.  
1.6 Aims and objectives 
In mouse zygotes, the conversion of 5-methylcytosine (5mC) to 5-hydroxymethycytosine 
(5hmC) and further oxidized forms by the Tet dioxygenase 3 (Tet3) in paternal and maternal 
genomes has been associated to the modification status of histone H3 at lysine 9 
(H3K9me2/3). Notably, as potential carriers for this histone mark, histone H3 variants, 
namely H3.1, H3.2, H3.3, are dynamically deposited into the chromatin in DNA replication 
dependent and independent manners, which may be responsible for the asymmetry. 
Additionally, based on the histone code hypothesis that phosphorylation, together with 
methylation, could serve as a critical “switch” on the transcription level, we speculate that the 
neighbouring sites to lysine 9 on histone H3 may potentially and coordinately function in 
maintainance of the asymmetry, further influencing DNA methylation in mouse zygotic stage. 
In this thesis, the following questions would be addressed.  
(I) How does the differential deposition of histone H3 variants into maternal and 
paternal pronuclei contributes to histone H3 and DNA modifications asymmetry? 
(II) Does any other modification act as an upstream switch for regulation of H3K9me2 
in the maternal pronucleus? 
(III) Does the preferential accumulation of H3.3 variant in paternal pronucleus plays 
role in paternal DNA demethylation? 
(IV) How would the induced artificial abundance of H3K9me2 in the paternal genome 
influence DNA methylation reprogramming in mouse zygote?
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2 Materials and Methods 
2.1 Materials 
2.1.1 Mouse strains 
We used adult F1 (♂BDA x ♀C57Bl6) mice (at least two-month-old), which were bred in our 
laboratory.  
2.1.2 Chemicals 
Chemicals Suppliers 
Acidic Tyrode’s Sigma-Aldrich, Taufkirchen, Germany 
Acrylamide/Bis-acrylamide(30%) Carl Roth, Karlsruhe, Germany 
Agar Carl Roth, Karlsruhe, Germany 
APS (10%) Carl Roth, Karlsruhe, Germany 
Blotting Grade Blocker Bio-Rad, California, USA 
Bromophenol blue Serva, Heidelberg, Germany 
BSA Sigma-Aldrich, Taufkirchen, Germany 
Calcium chloride Sigma-Aldrich, Taufkirchen, Germany 
Chaetocin Sigma-Aldrich, Taufkirchen, Germany 
Chromo-sulphuric acid Sigma-Aldrich, Taufkirchen, Germany 
Chloroform Sigma-Aldrich, Taufkirchen, Germany 
Cycloheximide Sigma-Aldrich, Taufkirchen, Germany 
DAPI Sigma-Aldrich, Taufkirchen, Germany 
DAB Carl Roth, Karlsruhe, Germany 
dNTPs MBI Fermentas, St.Leon-Rot, Germany 
Dextran Tetramethylrhodamine Invitrogen, Karlsruhe, Germany 
DMSO Sigma-Aldrich, Taufkirchen, Germany 
5%DMDCS in toluene Supelco, Bellefonte, USA 
Disodium hydrogen phosphate Carl Roth, Karlsruhe, Germany 
DNA Ladder 1kb Thermoscientific, Schwerte, Germany 
DTT Sigma-Aldrich, Taufkirchen, Germany 
EDTA Sigma-Aldrich, Taufkirchen, Germany 
Ethanol Carl Roth, Karlsruhe, Germany 
Ethidium bromide Carl Roth, Karlsruhe, Germany 
Glucose Carl Roth, Karlsruhe, Germany 
Glycerol Carl Roth, Karlsruhe, Germany 
hCG  Interved, Unterschleissheim, Germany 
HEPES Serva, Heidelberg, Germany 
Hoechst 33342 Invitrogen, Karlsruhe, Germany 
Hydrogen peroxide Sigma-Aldrich, Taufkirchen, Germany 
Imidazole Carl Roth, Karlsruhe, Germany 
IPTG Carl Roth, Karlsruhe, Germany 
Isopropyl alcohol Carl Roth, Karlsruhe, Germany 
Kanamycin sulfate Sigma-Aldrich, Taufkirchen, Germany 
Manganese(II) chloride Sigma-Aldrich, Taufkirchen, Germany 
Magnesium sulfate Sigma-Aldrich, Taufkirchen, Germany 
Methanol Carl Roth, Karlsruhe, Germany 
Mercury Sigma-Aldrich, Taufkirchen, Germany 
Mineral oil Sigma-Aldrich, Taufkirchen, Germany 
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Milli-Q Water Millipore Milli Q plus 
Mounting Medium Vector Labs, Loerrach, Germany 
NEB buffer 3 New England Biolabs, USA 
NEB buffer 4 New England Biolabs, USA 
NEB BSA (100x)  New England Biolabs, USA 
Nickel(II) chloride Sigma-Aldrich, Taufkirchen, Germany 
Nuclease-Free Water Ambion, Darmstadt, Germany 
Paraformaldehyde Sigma-Aldrich, Taufkirchen, Germany 
PCR Buffer 10x Qiagen, Hilden, Germany 
Pefabloc® SC-Protease Inhibitor Carl Roth, Karlsruhe, Germany 
Penicillin/Streptomycin PAA, Coelbe, Germany 
Phenol:Chloroform:Isoamyl Alcohol 
Mixture 
Sigma-Aldrich, Taufkirchen, Germany 
Phusion® HF Buffer New England Biolabs, USA 
PMSG  Interved, Unterschleissheim, Germany 
Polyvinylpyrrolidone Sigma-Aldrich, Taufkirchen, Germany 
Potassium chloride Carl Roth, Karlsruhe, Germany 
Potassium dihydrogen phosphate Carl Roth, Karlsruhe, Germany 
Potassium hydroxide Sigma-Aldrich, Taufkirchen, Germany 
Q5® Reaction Buffer New England Biolabs, USA 
Salmon Sperm DNA Thermoscientific, Schwerte, Germany 
Sodium azide Sigma-Aldrich, Taufkirchen, Germany 
Sodium chloride Carl Roth, Karlsruhe, Germany 
Sodium dodecyl sulfate (SDS) Sigma-Aldrich, Taufkirchen, Germany 
Sodium hydroxide  Sigma-Aldrich, Taufkirchen, Germany 
TEMED Carl Roth, Karlsruhe, Germany 
Tetracycline Sigma-Aldrich, Taufkirchen, Germany 
Tris-HCl Carl Roth, Karlsruhe, Germany 
Triton X-100 Sigma-Aldrich, Taufkirchen, Germany 
Tween 20 Sigma-Aldrich, Taufkirchen, Germany 
Tryptone Carl Roth, Karlsruhe, Germany 
X-Gal Carl Roth, Karlsruhe, Germany 
Yeast extract Carl Roth, Karlsruhe, Germany 
2.1.3 Antibodies 
Name (Manufacture, Catalog#) Dilution Application 
Anti-H3K9me2 (gift from Thomas Jenuwein, rabbit 
polyclonal) 
1:1000 IF/WB 
Anti-H3K9me2 (Abcam, #ab1220, mouse monoclonal) 1:1000 WB 
Anti-H3K9me3 (Millipore, #07-442, rabbit ployclonal) 1:200/1:500 IF/WB 
Anti-H3K9ac (Cell Signaling, #9671, rabbit 
ployclonal) 
1:200 IF 
Anti-H3S10phos (Cell Signaling, #3377, rabbit 
monoclonal) 
1:100 IF 
Anti-H3T11phos (Cell Signaling, #9767, rabbit 
monoclonal) 
1:100 IF 
Anti-gH2AX (US Biological, #H5110-03K2, rabbit 
ployclonal ) 
1:250 IF 
Anti-G9a (abcam, #ab31874, rabbit ployclonal) 1:100 IF 
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Anti-5mC (Calbiochem, #NA81, mouse monoclonal) 1:1000 IF 
Anti-5hmC (Active motif, #39791, rabbit ployclonal) 1:1000 IF 
Anti-5caC (Active motif, #61225, rabbit ployclonal) 1:2000 IF 
Anti-ssDNA (Immuno-Biological Laboratories, 
#18731, rabbit ployclonal) 
1:400 IF 
Anti-GFP (Roche #11814460001, mouse monoclonal) 1:1000 WB 
Anti-GFP (Antibodies-online GmbH, #AA1-246, goat 
polyclonal) 
1:2000 IF/WB 
Anti-mouse IgG Alexa Fluor® 647 (Life Technologies, 
#A-21237) 
1:200 IF 
Anti-rabbit IgG Rhodamine Red-X (Jackson 
ImmunoResearch Laboratories Inc., #83473) 
1:500 IF 
Donkey Anti-Goat IgG Antibody (abcam, #ab6566) 1:1000 IF 
Goat Anti-Mouse IgG Antibody, HRP conjugate 
(Millipore, #AP308P) 
1:5000 WB 
Goat Anti-Rabbit IgG Antibody, HRP-conjugate 
(Millipore, #12-348) 
1:2500 WB 
Donkey Anti-Goat IgG H&L (HRP) (abcam, #ab6885) 1:5000 WB 
2.1.4 Enzymes 
Enzymes Suppliers 
GeneRuler 1 kb DNA Ladder Thermoscientific, Schwerte, Germany 
HotFire DNA Polymerase Solis BioDyne, Tarta, Estonia 
Hyaluronidase Sigma-Aldrich, Taufkirchen, Germany 
Klenow Fragment Thermoscientific, Schwerte, Germany 
Pfu DNA Polymerase New England Biolabs, USA 
Phusion® DNA Polymerase New England Biolabs, USA 
Proteinase K Zymo Research Europe, Germany 
Protein Ladder (SM0671) Thermoscientific, Schwerte, Germany 
Q5® DNA Polymerase New England Biolabs, USA 
Taq DNA Polymerase New England Biolabs, USA 
T4 DNA ligase New England Biolabs, USA 
BsaWI New England Biolabs, USA 
Eco47I Thermoscientific, Schwerte, Germany 
NcoI New England Biolabs, USA 
NdeI New England Biolabs, USA 
SaII New England Biolabs, USA 
XhoI New England Biolabs, USA 
2.1.5 Prokaryotic cells 
E.coli Top10 cells were used for sub-cloning the coding sequences, to generate plasmid 
templates for in vitro transcription, or to generate vectors for proteins expression in Rosetta 
(DE3) E.coli cells (Novagen). 
2.1.6 Mediums 
Mediums Suppliers 
Gibco Fetal Bovine Serum Life Technologies, Darmstadt, Germany 
KSOM Millipore, Schwalbach-Ts, Germany 
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M2-Medium Millipore, Schwalbach-Ts, Germany 
M2-Medium without BSA Millipore, Schwalbach-Ts, Germany 
KSOM with 30 mg/ml BSA Self-made 
LB-Medium Self-made 
SOC-Medium Self-made 
2.1.7 Solutions and buffers 
(1) Blocking solution: 1% BSA, 0.01% triton X-100, 0.05% NaN3, dissolved in 1x PBS 
solution.  
(2) DNA loading buffer (6x): 4g sucrose, 25mg bromophenol blue, 25mg xylene cyanol, add 
distilled water to 10mL. 
(3) Elution buffer (1L):  50mM NaH2PO4, 500mM NaCl, 300mM imidazole, adjust pH to 8.0 
using NaOH.  
(4) Lysis buffer (1L): 50mM NaH2PO4, 500mM NaCl, adjust pH to 8.0 using NaOH. 
(5) PBS (1L, 10x) without Mg
2+
 and Ca
2+
: 80g NaCl, 2g KCl, 2.7g KH2PO4, 14.4g Na2HPO4, 
adjust pH to 7.4. 
(6) Permeablization solution: 0.2% triton X-100, 0.05% NaN3, dissolved in 1x PBS solution.  
(7) Sample loading buffer (10mL, 4x): 2.5ml of 1M Tris-HCl (pH 6.8), 1.0g SDS, 0.8mL of 
0.1% bromophenol blue, 4mL of 100% glycerol, 2mL of 14.3M β-mercaptoethanol (100% 
stock).  
(8) TAE buffer (1L, 50x): 242g Tris base, 57.1mL glacial acetic acid, 100mL 0.5M EDTA, 
bring final volume to 1L and store at room temperature. 
(9) Washing buffer (1L): 50mM NaH2PO4, 500mM NaCl, 5mM imidazole, adjust pH to 8.0 
using NaOH. 
2.1.8 Primers 
Name Sequence (5’ to 3’) Application 
H3.1-GFPWild type 
FWD 
CATGCCATGGCTCGTACTAAGCAGACCGC Cloning 
H3.1-GFPWild type 
REV 
CCGCTCGAGGCCGCCAGCCCTCTCCCCGCGGATGCGGC Cloning 
H3.2-GFPWild type 
FWD 
CATGCCATGGCCCGTACGAAGCAGACTGC Cloning 
H3.2-GFPWild type 
REV 
CCGCTCGAGGCCGCCAGCGCGCTCCCCACGGATGCGG Cloning 
H3.3-GFPWild type 
FWD 
CATGCCATGGCTCGTACAAAGCAGACTGC Cloning 
H3.3-GFPWild type 
REV 
CCGCTCGAGGCCGCCAGCACGTTCTCCGCGTATGCGGC Cloning 
MutGeneralPCR1 FWD CCTGCCACCATACCCACGCCGAAAC Mutagenesis 
H3.1-GFPK9RPCR1 
REV 
GCCTTGCCGCCGGTAGAGCGGCGAGCGGTCTGCTTAGT Mutagenesis 
H3.1-GFPK9RPCR2 
FWD 
ACTAAGCAGACCGCTCGCCGCTCTACCGGCGGCAAGGC Mutagenesis 
MutGeneralPCR2 REV CGTAGGTCAGGGTGGTCACGAGGGT Mutagenesis 
H3.2-GFPK9RPCR1 
REV 
GCCTTGCCGCCAGTGGAGCGGCGAGCGGTCTGCTTCG Mutagenesis 
H3.2-GFPK9RPCR2 
FWD 
CGAAGCAGACCGCTCGCCGCTCCACTGGCGGCAAGGC Mutagenesis 
H3.3-GFPK9RPCR1 
REV 
GTGCTTTACCACCGGTGGAGCGGCGGGCAGTCTGCTTTGT Mutagenesis 
H3.3-GFPK9RPCR2 
FWD 
ACAAAGCAGACTGCCCGCCGCTCCACCGGTGGTAAAGCAC Mutagenesis 
H3.1-GFPS10APCR1 
REV 
CGGGGCCTTGCCGCCGGTGGCCTTGCGAGCGGTCTGCT Mutagenesis 
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H3.1-GFPS10APCR2 
FWD 
AGCAGACCGCTCGCAAGGCCACCGGCGGCAAGGCCCCG Mutagenesis 
H3.2-GFPS10APCR1 
REV 
CGGGGCCTTGCCGCCAGTGGCCTTGCGAGCGGTCTGCT Mutagenesis 
H3.2-GFPS10APCR2 
FWD 
AGCAGACCGCTCGCAAGGCCACTGGCGGCAAGGCCCCG Mutagenesis 
H3.3-GFPS10APCR1 
REV 
CTGGGTGCTTTACCACCGGTGGCTTTGCGGGCAGTCTGC Mutagenesis 
H3.3-GFPS10APCR2 
FWD 
GCAGACTGCCCGCAAAGCCACCGGTGGTAAAGCACCCAG Mutagenesis 
H3.1-GFPT11APCR1 
REV 
CGCGGGGCCTTGCCGCCGGCAGACTTGCGAGCGGTCTGC Mutagenesis 
H3.1-GFPT11APCR2 
FWD 
GCAGACCGCTCGCAAGTCTGCCGGCGGCAAGGCCCCGCG Mutagenesis 
H3.2-GFPT11APCR1 
REV 
CGCGGGGCCTTGCCGCCGGCGGACTTGCGAGCGGTCTGC Mutagenesis 
H3.2-GFPT11APCR2 
FWD 
GCAGACCGCTCGCAAGTCCGCCGGCGGCAAGGCCCCGCG Mutagenesis 
H3.3-GFPT11APCR1 
REV 
CTGGGTGCTTTACCACCGGCGGATTTGCGGGCAGTCTGC Mutagenesis 
H3.3-GFPT11APCR2 
FWD 
GCAGACTGCCCGCAAATCCGCCGGTGGTAAAGCACCCAG Mutagenesis 
H3.1-GFPK9QPCR1 
REV 
GCCTTGCCGCCGGTAGACTGGCGAGCGGTCTGCTTAGT Mutagenesis 
H3.1-GFPK9QPCR2 
FWD 
ACTAAGCAGACCGCTCGCCAGTCTACCGGCGGCAAGGC Mutagenesis 
HDAC1-GFP FWD GCGCAGACTCAGGGCACCAAGAGGAAAG Cloning 
HDAC1-GFP REV AGAATTCGTCGACCTCGAGGCCGGCCAACTTGACCTCTTCTTTG
AC 
Cloning 
HDAC2-GFP FWD GCGTACAGTCAAGGAGGCGGCAAGAAGAAAGTGT Cloning 
HDAC2-GFP REV GAATTCCTCGAGGCCAGGGTTGCTGAGTTGTTCTGACTTGGCT Cloning 
G9aFL-GFP FWD CGGGGTCTGCCGAGAGGGAGGGGGCTGATGCGGGCCCG Cloning 
G9aFL-GFP REV CCGCTCGAGGGTGTTGATGGGGGGCAGGGAGCTGAG Cloning 
G9aCat FWD GTCTTCTGTCCCCACTGTGGAG Cloning 
G9aCat REV CCGCTCGAGTTAGGTGTTGATGGGGGGCAGGGAGCTGAG Cloning 
G9aCat-GFP FWD GTCTTCTGTCCCCACTGTGGAG Cloning 
G9aCat-GFP REV CCGCTCGAGGGTGTTGATGGGGGGCAGGGAGCTGAG Cloning 
G9aCat-NLS-GFP FWD GTCTTCTGTCCCCACTGTGGAG Cloning 
G9aCat-NLS-GFP REV TGGCCGACGTCGACGGTGTTGATGGGGGGCAGGGAGCTGAG Cloning 
LINE1 FWD TGGTAGTTTTTAGGTGGTATAGAT Sequencing 
LINE1 REV TCAAACACTATATTACTTTAACAATTCCCA Sequencing 
IAP FWD TTTTTTTTTTAGGAGAGTTATATTT Sequencing 
IAP REV ATCACTCCCTAATTAACTACAAC Sequencing 
mSAT FWD GGAAAATTTAGAAATGTTTAATGTAG Sequencing 
mSAT REV AACAAAAAAACTAAAAATCATAAAAA Sequencing 
T7 promoter TAATACGACTCACTATAGGG Sequencing 
T7 upstream TGCGTCCGGCGTAGAGGATCG mRNA prep 
T7 terminator GCTAGTTATTGCTCAGCGG mRNA prep 
eGFP1 REV GACACGCTGAACTTGTGGC Sequencing 
LINE1-Hairpin linker Tggtagtttttaggtggtatagattctcacttaagcagactaaattcctaagttccttggagtcccgggacca
agatg 
gcgaccgctgctgctgtggcttaggcgccccccagccgggcgggcacctgtcctccggtCCGGaG
nGRC 
CATnnnnnnnnATGGGRCCtccngaccggaggacaggtgcccgcccggctggggaggc
ggccT 
aagccAcagcagcagcggtcgccatcttggtcccgggactccaaggaacttaggaatttagtctgctta
agtgag 
agtctgtaccacctgggaattgttaaagtaatatagtgtttga 
Sequencing 
IAP-Hairpin linker Tcccttttttaggagagttatatttcgccttagacgtgtcactccctgattggctgcagcccatcggccgagt
tgacgt 
caAgttgacgtcacggggaaggcagagcacatggagtagagaaccacctcggcatatgcgcagatta
tttgttta 
ccacTTAgggRTTatNNNNNNNNatgggRTTtaagtggtaaacaaataatctgcgcatat
Gccgag 
ggtggttctctactccatgtgctctgccttccgtgacgtcaactcggccgatgggctgcagccaatcaggg
agtgac 
Sequencing 
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mSAT-Hairpin linker GgaaaatttagaaatgtttaatgtaggaCGtggaatatggcaagaaaactgaaaatcatgggaaatgag
aaac 
atccacttgtCGacttgaaaaatgaCGaaatcactaaaaaaCGtgaaaaatgagaaatgcacactga
aggN 
TgggRTTatNNNNNNNNatgggRTTgNccttcagtgtgcatttctcatttttcaCGtttttta
gtgattt 
CGtcatttttcaagtCGacaagtggatgtttctcattttttatgatttttagtttttttgtt 
Sequencing 
2.1.9 Reaction kits 
The DNA replication in mouse zygotes was confirmed by using Click-iT® EdU kit (Life 
Technologies, Darmstadt, Germany). The mRNA extraction from oocytes was performed by 
using Dynabeads® mRNA Purification Kit (Life Technologies, Darmstadt, Germany). The 
subsequent cDNA reverse transcription was completed with EndoFree Reverse Transcription 
Kit (Life Technologies, Darmstadt, Germany). The In vitro mRNA transcription and 
purification were done by using AmpliCap-Max™ T7 High Yield Message Maker Kit 
(CELLSCRIPT) and RNA Clean & Concentrator™-25 Kit (Zymo research), respectively. 
The bisulfite treatment was performed using EZ DNA Methylation-Gold™ Kit (Zymo 
research). The PCR fragments were purified with Gel/PCR DNA Fragments Extraction Kit 
(GeneAid). Plasmids were extracted by using GenElute™ Plasmid Miniprep Kit (Sigma-
Aldrich).  
2.1.10 Instruments 
Instruments Manufactures 
Axiovert 200M Inverted Microscope Zeiss, Germany 
Balance Sartorius, Bradford, USA 
BioStation IM Live Cell Recorder Nikon, Germany 
Borosilicate glass (GC100 TF-10) Harvard Apparatus, UK 
Borosilicate glass (GC100 TF-15) Harvard Apparatus, USA 
Cell Tram Air Eppendorf, Germany 
Cell Tram Vario Eppendorf, Germany 
Centrifuge Eppendorf, Germany 
CO2 Incubator Sanyo, Wood Dale, USA 
Concavity Slides Menzel, Germany 
Femtojet Eppendorf, Germany 
French Press Cell Disrupter Thermo scientific, Germany 
Gel Documentation System PEQLAB, Germany 
Glass capillary (Ringcaps® 50 µl) Hirschmann GmbH, Germany 
Heraeus® CO2-Inkubator Thermo scientific, Germany 
Micro-forge De Fonbrune Technical Products international 
Micromanipulator Eppendorf, Germany 
NanoDrop2000 Spectrophotometers Thermo scientific, Germany 
Needle Puller, Model P-87 Sutter, Novato, USA 
Nunc™ IVF Petri Dishes Thermo scientific, Germany 
PCR Cyclers (Applied Biosystems) Life Technologies, Germany 
Piezo Drill, PMAS-CT 150 Prime Tech, Japan 
Preparation instruments  Fine Science Tools, Germany 
Semi-Dry Blotting Systems Bio-Rad, Germany 
SMZ 800 Stereomicroscope Nikon, Germany 
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Glass Bottom Culture Dish (35mm) MatTek, Ashland, USA 
2.2 Methods 
2.2.1 Mouse superovulation and execution  
All animal experiments were performed according to the German Animal Welfare law in 
agreement with the authorizing committee. For superovulation, females were treated by 
injection of 6 IU pregnant mare serum gonadotropin (PMSG) and 6 IU human chorionic 
gonadotropin (hCG) in an intraperitoneal manner, with a time interval of around 48 hours. 
Mice were executed via cervical dislocation.  
2.2.2 RNA isolation 
The mRNA from oocytes was prepared by using the Reverse Transcription System according 
to the manufacture’s instructions. Briefly, oocytes were incubated with Lysis/Binding Buffer 
for 10min. Then 10µl Dynabeads oligo (dT)25 was added to the sample for another 10min 
incubation at room temperature (RT). After incubation, the sample tubes were placed in the 
Magnetic Separation Rack which could immobilize the magnetic beads with mRNAs on. 
Subsequently, Washing Buffer A and B in a volume of 100µl were applied to remove 
contaminating RNA species in this order, respectively. Lastly, the mRNAs were eluted in as 
little as 10µl of elution butter, which was used for downstream experiment immediately.  
2.2.3 cDNA reverse transcription 
The reverse transcription was performed in the following steps. Firstly, the mixture of RNA 
(7µl) and RT (1µl) primer was prepared. Meanwhile, a reaction mix was also done, including 
2µl 10x RT buffer, 8µl dNTPs, 1µl RNase inhibitor as well as 1µl Nuclease-free water. 
Secondly, incubation of the RNA: RT primer mixture at 72°C for 3min was done in a themal 
cycler. After that, it was quickly moved to 50°C for 3min. The reaction mix was done in the 
same way in parallel. Then the reaction mix was added to the RNA: RT primer mixture. Note 
that the temperature should be avoided below 48°C. Lastly, incubation was continued at 50°C 
for 2 hours after being added with 1µl of Reverse Transcriptase. The produced cDNA was 
immediately used for PCR amplification.   
2.2.4 Polymerase chain reaction (PCR) 
The cloning of G9a catalytic domain was performed using the cDNA mentioned above as 
template in the following PCR reaction.   
PCR components: (1) 10µl 10x Reaction buffer; (2) 2.5µl forward primer (10µM); (3) 2.5µl 
reverse primer (10µM); (4) 4µl dNTPs (2.5mM each); (5) 1µl cDNA template; (6) 0.5µl 
Phusion polymerase; (7) 29.5µl Nuclease-free water.  
PCR conditions: 
 
2.2.5 Plasmids preparation 
Materials and Methods 
 
22 
 
The cDNAs of H3.1, H3.2 (gifts from Prof. Dr. Fugaku Aoki, Japan), H3.3 (purchased from 
ImaGenes GmbH) were cloned to pEGUP1 (a modified pET28b containing eGFP after 
multiple cloning sites) by using NcoI and XhoI. The cDNA of G9a full length (gift from Prof. 
Dr. Y. Shinkai, M. Tachibana, M. Brand and M. R. Stallcup) was subcloned to our vector 
pEGUP1 by ligation with one end being blunt and the other end being sticky cut by Xhol. The 
same strategy was applied to G9aCat-GFP, HDAC1 (purchased from Addgene) as well as 
HDAC2 (gift from Prof. Dr. Richard M. Schultz, USA). For G9aCat-NLS-GFP, the fragment 
was ligated to pEGUP1-NLS (a modified pET28b containing NLS after multiple cloning 
sites) with one blunt end and one sticky end cut by SaII. For G9aCat, it was cloned into 
pET15Am (a modified pET28b containing ampicillin resistance marker, p15 origin and no 
His-tag sequences). All the positive constructs were verified by Sanger sequencing.  
Ligation components: (1) 1µl 10x Ligation buffer; (2) 1µl digested vector; (3) 4µl digested 
PCR fragments; (4) 1µl T4 DNA Ligase; (5) 3µl Milli-Q water. 
2.2.6 Site-specific mutagenesis 
The generation of all mutants (K9R, S10A, T11A) of histone H3.1/2/3 was done by over-
lapping PCR-based mutagenesis. Briefly, two PCRs, namely PCR1 and PCR2, were applied 
with two sets of primers in which reverse primer for PCR1 and forward primer for PCR2 are 
complementary and contain the mutation sites. After gel purification, the cleaned up 
fragments from PCR1 and PCR2 were mixed as templates in the Overlap PCR reactions. The 
expected PCR products were then double-digested by NcoI and XhoI, followed by ligation 
with pEGUP1. The positive clones containing the corresponding mutations were selected and 
confirmed by Sanger sequencing.    
PCR1 or PCR2 components: (1) 10µl 10x Reaction buffer; (2) 2.5µl forward primer (10µM); 
(3) 2.5µl reverse primer (10µM); (4) 4µl dNTPs (2.5mM each); (5) 0.5µl plasmid template; 
(6) 0.5µl Phusion polymerase; (7) 30µl Nuclease-free water.  
Overlap PCR components: (1) 20µl 10x Reaction buffer; (2) 5µl forward primer (10µM); (3) 
5µl reverse primer (10µM); (4) 8µl dNTPs (2.5mM each); (5) 5µl PCR1 product; (6) 5µl 
PCR2 product; (7) 0.5µl Phusion polymerase; (8) 51.5µl Nuclease-free water. 
PCR conditions:  
 
2.2.7 Acetylation-mimetic mutant of H3.1 
The mutation of lysine 9 to glutamine of H3.1 was performed using the same strategy 
aforementioned to mimic the acetylation status.   
2.2.8 In vitro transcription of mRNAs 
For preparation of cRNAs of all the constructs mentioned above, highly purified DNAs were 
extracted with Phenol:Chloroform, and high-quality capped mRNAs were generated by in 
vitro transcription using AmpliCap-Max T7 High Yield Message Maker Kit (CellScript, Inc.), 
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followed by purification using RNA Clean & Concentrator™-25 Kit (Zymo research) 
according to the manufacturers’ instructions. Finally, transcribed mRNAs were eluted with 
nuclease-free water (Life technologies), and stored at −80°C for later use within one month. 
2.2.9 Protein Purification  
For co-expression of G9aCat with histone H3.1-GFPWT, or H3.1-GFPT11A or H3.3-
GFPWT, both constructs were transformed into Rosetta™ 2 Competent Cells. Cells 
containing both constructs were grown in SOC medium with ampicillin (100mg/mL) and 
kanamycin (25mg/mL) until OD value reached 0.5-0.6 at 37°C, followed by 0.5mM 
isopropyl-b-D-thiogalactopyranoside (IPTG) induction for 24h at 16°C. Modified proteins of 
H3.1-GFPWT, H3.1-GFPT11A, H3.3-GFPWT were purified through Nickel nitrilotriacetic 
(Ni-NTA) resin by taking advantage of the 6xHis tag. The same procedure was respectively 
applied to H3.1-GFPWT and H3.3-GFPWT without co-expression. H3.3-GFPWT and H3.3-
GFPK9me2 proteins were further gradually dialysed with PBS buffer overnight at 4°C. The 
protein expression was confirmed by Coomassie Blue staining of SDS-PAGE gel. 
2.2.10 Verification of H3K9me2 by Western blotting  
Western blotting was performed to check whether dimethyl group was successfully 
transferred to K9 on histone H3.1-GFP, H3.1-GFPT11A or H3.3-GFP. After purification, the 
proteins were added with loading buffer, heated at 100°C for 3-5min and loaded onto the 
SDS-PAGE gel. After running, the proteins were electrotransferred to the PVDF membrane at 
15V for 45min, followed by blocking for around 2h. Then the membrane was incubated with 
primary antibodies, followed by HRP conjugated secondary antibody incubation with three 
times washing between two steps. In the end, DAB was applied for detection following the 
manufacturer’s instructions.   
2.2.11 In vitro fertilization  
Spermatozoa isolation, oocytes collection and IVF procedures were carried out as previously 
published protocol with small modifications (Wossidlo et al., 2010). Briefly, sperm were 
isolated from the cauda epididymis of male mice and capacitated in pre-gassed modified 
KSOM medium supplemented with 30 mg/ml BSA for 2h. Mature oocytes were collected 15h 
post-human chorionic gonadotropin (hCG) injection of female mice according to the standard 
protocol (Nagy et al., 2003). Cumulus–oocyte complexes (COCs) were placed into a 400μl 
drop of KSOM medium, mixed with capacitated sperm and incubated at 37°C in a humidified 
atmosphere of 5% CO2 and 95% air. 
2.2.12 Embryo culture 
At around 2 to 3hpf, the zygotes were collected and washed several times in M2 medium. 
Subsequently, they were transferred to 100μl drops of pre-gassed KSOM medium covered 
with mineral oil in a Petri dish. They were cultured to the desired stage for fixation. 
2.2.13 Chaetocin treatment  
At 3h post fertilization, Chaetocin with a concentration of 1μM was added into the 400μl drop 
of KSOM medium. Meanwhile, ethonal was applied as the control treatment. Then the 
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zygotes were cultured to post-replication stage (PN4/5), followed by fixation for 
immunostaining.  
2.2.14 Cycloheximide treatment and Edu labelling 
At the beginning of fertilization, cycloheximide with a concentration of 50μg/ml was added 
into the 400μl drop of KSOM medium, as used in the literature (Liu et al., 2004). For the Edu 
labelling, it was performed according to manufacture’s instructions. Briefly, after 3hpf, the 
zygotes were transferred into 100μl KSOM containing 2μl of cycloheximide and 1μl of Edu 
diluted from the stock solution in the kit. Then the zygotes were cultured to replication stage 
(late PN3 or PN4), followed by fixation for 30min, permeablization for 30min, and blocking 
for 3h at RT. Then the reaction cocktail was applied for incubation for 1h at RT. After 
washing in the blocking solution, the anti-gamma H2A.X antibodies were incubated, followed 
by the protocol mentioned below for immunostaining. 
2.2.15 Preparation of microinjection needles 
Fine tipped glass needles were prepared by a puller under the following conditions. (1) 
Temperature: Ramp-Test+5; (2) Traction force: 80; (3) Speed: 80; (4) Time: 200; (5) Druck: 
200;  
2.2.16 Microinjection of mRNAs or proteins into zygotes 
At around 1hpf, just before microinjection, zygotes were collected, washed in M2 medium for 
several times and transferred into 100μl drops of pre-gassed KSOM medium. Microinjection 
was performed under a Zeiss Axiovert 200M inverted microscope (Zeiss) equipped with a 
microinjector and Piezo-driven micromanipulators (Eppendorf). After a quick setup according 
to the procedures described in the laboratory manual entitled “Manipulating the mouse 
embryo” (Nagy et al., 2003), zygotes were placed into a M2 medium  drop of 20μl and 
cytoplasm injection was done with mRNAs or proteins, respectively. 
2.2.17 Triton treatment of zygotes 
Zygotes injected with histone H3WTs and K9R mutants were treated exactly as previously 
reported (Nakamura et al., 2012). After the last washing with PBS, the zygotes were fixed for 
immunostaining as mentioned below.  
2.2.18 Chromatin incorporation of histone H3 variants monitored by live 
imaging 
After being microinjected with mRNAs of histone H3 WTs or K9R mutants at around 1hpf, 
respectively, the zygotes were transferred into a KSOM drop of 10µl on a glass bottom 
culture dish (35mm) and placed into the chamber of Live Cell Screening Systems. The 
chamber was under the condition of 37°C in a humidified atmosphere of 5% CO2 and 95% 
air. The pictures were captured every 15min for 97 cycles with the exposure time being 
1/250s.  
2.2.19 Immunofluorescence staining 
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The embryos were fixed at desired stages in 3.7% PFA. The detailed protocol was well 
described in the published papers (Wossidlo et al., 2010; Wossidlo et al., 2011). All the 
antibodies used were shown in Materials Part (2.1.3 Antibodies). 
2.2.20 IF Microscopy, quantification and statistical analysis 
The mounted embryos were analysed on Zeiss Axiovert 200M inverted microscope equipped 
with the fluorescence module and B/W digital camera for imaging. The IF images were 
captured, pseudocoloured and merged using AxioVision software (Zeiss). GIMP and Image J 
softwares were applied together to complete quantification of the signals of z-stack computed 
images. For each group, at least 10 zygotes were analysed from at least two repeated 
experiments. Student's t-test was employed for statistical analysis. 
2.2.21 Hairpin bisulfite sequencing 
The tube containing the zygotes in M2 medium was added with 1µl lysis buffer, 1µl salmon 
sperm DNA (100ng/µl) as well as 1µl proteinase K (1ng/µl) and incubated at 55°C over night. 
The reaction was stopped by putting 0.7µl Pefabloc (8.14µM) to the sample. The DNA was 
then cut in an 8µl reaction mixture containing 0.8µl buffer, 5-10U of restriction enzyme and 
1µl 5mM MgCl2. As for restriction enzymes, BsaWI (NEB) was used for LINE1, DdeI (NEB) 
for IAPs  and Eco47I (Thermo Scientific) for mSat. The reaction was incubated for 3h. 
Temperatures were adjusted according to the enzymes. After digestion, the ligation of the 
hairpin linker was done by adding 200U T4 DNA ligase, 1µl ATP and 1µl HP-Linker and 
incubating for 16h at 16°C. The bisulfite treatment was performed using the GOLD kit from 
Zymo Research. Amplicons were generated in a PCR using the HotFire polymerase 
(SolisBioDyne) and the primers shown in Materials Part (2.1.8 Primers). In the case of L1 and 
IAP the reactions were supplied with HotStartIT binding protein. The fragments were purified 
by gel electrophoresis and cleaned with Gel/PCR DNA Fragments Extraction Kit. The 
Sequencing was performed on an Illumina MiSeq platform. The analysis was done using 
BiQAnalyzerHT and python scripts. 
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3 Results 
3.1 Effects of K9R mutation of H3.1/2/3 on modifications of both 
histone and DNA in mouse zygotes 
DNA demethylation preferentially occurs in the paternal genome of mouse zygotes based on 
the Immunofluorescence, which is further confirmed by deep sequencing on the molecular 
level (Arand et al., 2015; Smallwood et al., 2011; Smith et al., 2012). Recently, Nakamura et 
al. demonstrated that H3K9me2, together with PGC7, serves as a protector for DNA 
methylation in the maternal genome, as well as some imprinted loci in the paternal one 
(Nakamura et al., 2007; Nakamura et al., 2012). Notably, H3K9me2 could theoretically take 
place on different histone H3 variants, namely H3.1, H3.2 and H3.3. For this reason, the site 
mutation of K9R was introduced on H3.1, H3.2 and H3.3 to address the question that which 
histone H3 variant is enriched with K9me2.   
3.1.1 Dynamic pattern of H3K9me2 through DNA replication  
To dissect the relations between histone H3 variants and H3K9me2 in mouse zygotes, we first 
evaluated the dynamic pattern of H3K9me2 during replication. It showed a reduction via 
DNA replication in the maternal pronucleus. In contrast, a slight but significant increase in de 
novo H3K9me2 was obtained in the paternal pronucleus (Fig. 3.1a, b), as reported previously 
(Liu et al., 2004; Santos et al., 2005).  
 
   
Fig. 3.1 Dynamic changes of H3K9me2 through DNA replication in mouse zygotes. a, Representative 
images of pre- and post replication stage zygotes stained with antibodies against H3K9me2. H3K9me2, red; 
Dapi, blue; b, Quantification of H3K9me2 signal normalized against Dapi signal in both parental genomes in 
pre- and post replication stages. Blue and red stand for pre-replication and post-replication stage, respectively. m, 
the maternal pronucleus; p, the paternal pronucleus; pb, polar body. Asterisks showed significant changes using 
Student’s t-tests (***=P<0.001). Error bars indicated s.d. For each group, at least 10 zygotes were analysed from 
at least two repeated experiments. 
3.1.2 Dynamic pattern of H3K9me3 through DNA replication  
Through quantification of H3K9me3 signal in pre- and post-replicative stages, it showed that 
H3K9me3 followed a similar to H3K9me2 dilution model in the maternal pronucleus, while it 
was completely absent from the paternal one.  
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Fig. 3.2 Dynamic changes of H3K9me3 through DNA replication in mouse zygotes. a, Representative 
images of pre- and post replication stage zygotes stained with antibodies against H3K9me3. b, Quantification of 
H3K9me3 signal normalized against Dapi signal in both parental genomes in pre- and post replication stages. 
Blue and red stand for pre-replication and post-replication stage, respectively. H3K9me3, red; Dapi, blue; m, the 
maternal pronucleus; p, the paternal pronucleus; pb, polar body. Asterisks showed significant changes using 
Student’s t-tests (***=P<0.001). Error bars indicated s.d.. For each group, at least 10 zygotes were analysed 
from at least two repeated experiments. 
3.1.3 Dynamic pattern of H3K9ac through DNA replication  
Upon fertilization, H3K9ac is readily detectable in both pronuclei. It is slightly more abundant 
in the paternal genome. At the commencement of replication, H3K9ac is increasingly 
accumulated in both genomes.  
 
   
Fig. 3.3 Dynamic changes of H3K9ac through DNA replication in mouse zygotes. a, Representative images 
of pre- and post replication stage zygotes stained with antibodies against H3K9ac. b, Quantification of H3K9ac 
signal normalized against Dapi signal in both parental genomes in pre- and post replication stages. Blue and red 
stand for pre-replication and post-replication stage, respectively. H3K9ac, red; Dapi, blue; m, the maternal 
pronucleus; p, the paternal pronucleus; pb, polar body. Asterisks showed significant changes using Student’s t-
tests (***=P<0.001). Error bars indicated s.d. For each group, at least 10 zygotes were analysed from at least two 
repeated experiments. 
3.1.4 Nuclear localization and chromatin incorporation of H3.1/2/3-GFPWTs 
and K9R mutants  
By tracing the GFP signal, we could clearly see the nuclear distribution of both H3.1/2/3-
GFPWTs and K9R mutants in mouse zygotes (Fig. 3.4). Only PN3 stage was shown for H3.1 
and H3.2, because they are replication-dependent.  
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Fig. 3.4 Nuclear localization of H3.1/2/3-GFPWT and K9R mutants. H3.1 or H3.2-GFPWTs or K9R injected 
groups were fixed at replication stage (PN3), whereas H3.3-GFPWT or K9R injected groups were captured at 
pre (PN2), middle (PN3) and post (PN4) replication stages, respectively. GFP signal, green. For each group, at 
least 10 zygotes were analysed from at least two repeated experiments. 
However, notably, the nuclear localization does not mean histone incorporation into the 
chromatin. Due to this fact, we first introduced triton treatment before fixation, which in 
principle could drive the free histones out of the nuclear, leaving the chromatin-bound 
histones inside the nuclear. As expected, we found that H3.3-GFPWT displayed a preferential 
localization in the paternal pronucleus before and during replication. Later, a balanced 
distribution of H3.3-GFPWT was seen between paternal and maternal pronuclei after 
replication, which is consistent with the published data (Santenard et al., 2010; Torres-Padilla 
et al., 2006; van der Heijden et al., 2005), while H3.1/2-GFPWTs exhibited the same pattern 
regardless of introduction of triton treatment. Intriguingly, when lysine 9 on H3.3 was 
replaced by arginine, it showed generally weaker signals than its WT counterpart in PN2 
stage. Also, during replication stage, it showed equal deposition into the chromatin in both 
pronuclei, while its wild type remained to be asymmetrically distributed during this time 
window. Taken together, it gave a hint that lysine 9 on H3.3 might be involved in its 
deposition into chromatin (Fig. 3.5).  
 
Fig. 3.5 Chromatin incorporation of H3.1/2/3-GFPWT and K9R mutants after introducing triton 
treatment before fixation. H3.1/H3.2-GFPWTs or K9R expressing zygotes were fixed at PN3, and H3.3-
GFPWT or K9R expressing zygotes were arrested at PN2, PN3 and PN4 stages. Representative images of 
zygotes stained with antibodies against GFP were shown. For each group, at least 10 zygotes were analysed from 
at least two repeated experiments. 
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Later, H3.1/2/3-GFPWTs and K9R mutants expressing zygotes were monitored by live 
imaging, which clearly showed the chromosomal localization of ectopically expressed 
histones during metaphase stage, strongly indicative of their successful incorporation into the 
chromatin after microinjection (Fig. 3.6). Otherwise, the green signal would show a 
homogenous localization in the cytoplasm.  
 
Fig. 3.6 Chromatin incorporation of H3.1/2/3-GFPWT and K9R mutants monitored by live cell imaging. 
The representative images of H3.1/2/3-GFPWTs or K9R mutants expressing mouse zygotes were shown at 
metaphase stage. GFP signal, green. For each group, at least 10 zygotes were analysed from at least two repeated 
experiments.  
3.1.5 Effects of H3.1/2/3-GFPK9R on H3K9me2   
Next, we tried to address the following questions:  
(I) Does the reduction of H3K9me2 during replication follow a simple dilution model or 
whether it involves the de novo methylation activity? 
(II) Can newly synthesized exogenous histone H3.1/2/3-GFPK9R replace the old histones 
carrying H3K9me2 during the replication coupled dilution process?  
(III) Which histone variant would be the main carrier of H3K9me2?  
In fact, the immunostaining results showed rather comparable signal intensities of H3K9me2 
between K9R mutants, WTs injected and non-injected groups (Fig. 3.7a, b, c). 
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Fig. 3.7 Influences on H3K9me2 in zygotes expressing H3.1/2/3-GFPWT and K9R. a, b, c, Representative 
images of PN4/5 stage zygotes stained with antibodies against H3K9me2. H3K9me2, red; Dapi, blue. m, the 
maternal pronucleus; p, the paternal pronucleus; pb, polar body. For each group, at least 10 zygotes were 
analysed from at least two repeated experiments.  
Having a closer view by signal quantification, we found that WTs indeed failed to disrupt 
H3K9me2. However, all the K9R mutants caused a minor reduction in H3K9me2 in the 
maternal pronucleus, of which H3.1/2K9R and H3.3K9R showed a relatively major and minor 
but significant effect, respectively, compared to the non-injected controls (Fig. 3.8), 
suggesting that H3.1 and H3.2 are more enriched with H3K9me2 than H3.3. Moreover, K9R 
mutants but not WTs slightly impaired H3K9me2, indicating that de novo H3K9me2 indeed 
took place during replication and strongly pointing out that the loss of H3K9me2 in a 
replication-dependent manner does not follow a simple dilution pathway but involves re-
methylation process.   
 
Fig. 3.8 Quantification of H3K9me2 signal normalized against Dapi signal in both parental genomes of 
zygotes expressing H3.1/2/3-GFPWT or K9R. Non-injected groups, grey; H3.1/2/3-GFPWT injected groups, 
dark green; H3.1/2/3-GFPK9R injected groups, light green; Asterisks showed significant changes using 
Student’s t-tests (***=P<0.001, **=P<0.01, *=P<0.05). The quantified values in control group were set to 1. 
Error bars indicated s.d.. For each group, at least 10 zygotes were analysed from at least two repeated 
experiments. 
3.1.6 Effects of H3.1/2/3-GFPK9R on H3K9me3   
Since the minor effects on H3K9me2 by H3.1/2/3K9R-GFP were observed, we also checked 
the alteration of H3K9me3. As a result, similar observations were obtained for H3K9me3 
based on the immunostaining, shown in Fig. 3.9 a, b, c.  
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Fig. 3.9 Influences on H3K9me3 in zygotes expressing H3.1/2/3-GFPWT and K9R a, b, c, Representative 
images of PN4/5 stage zygotes stained with antibodies against H3K9me3. H3K9me3, red; Dapi, blue. m, the 
maternal pronucleus; p, the paternal pronucleus; pb, polar body. For each group, at least 10 zygotes were 
analysed from at least two repeated experiments. 
Then we quantified the signals of H3K9me3 only from the maternal pronucleus in different 
groups, owing to its absence in the paternal one. As indicated on Fig. 3.10, significant 
reduction in H3K9me3 was caused by K9R mutation on H3.1/2-GFP, but not H3.3-GFP, 
indicating that the repressive mark H3K9me3 is distributed on H3.1 and H3.2, but not on 
H3.3.  
 
Fig. 3.10 Quantification of H3K9me3 signal normalized against Dapi signal in the paternal genome of 
zygotes expressing H3.1/2/3-GFPWT or K9R. Non-injected groups, grey; H3.1/2/3-GFPWT injected groups, 
dark green; H3.1/2/3-GFPK9R injected groups, light green; Asterisks showed significant changes using 
Student’s t-tests (**=P<0.01). The quantified values in control group were set to 1. Error bars indicated s.d.. For 
each group, at least 10 zygotes were analysed from at least two repeated experiments. 
3.1.7 Effects of H3.1/2/3-GFPK9R on H3K9ac   
Due to the fact that the rather dramatic increase of H3K9ac was obtained through replication 
in both pronuclei, we anticipated that, theoretically, K9R mutation at least on one of H3.1/2/3-
GFP variants may affect H3K9ac level. Nevertheless, unexpectedly, it displayed no 
differential signal intensities of H3K9ac between groups based on the immunofluorescence 
(Fig. 3.11). 
Results 
 
32 
 
 
Fig. 3.11 Influences on H3K9ac in zygotes expressing H3.1/2/3-GFPWT and K9R. a, b, c, Representative 
images of PN4/5 stage zygotes stained with antibodies against H3K9ac. H3K9ac, red; Dapi, blue. m, the 
maternal pronucleus; p, the paternal pronucleus; pb, polar body. For each group, at least 10 zygotes were 
analysed from at least two repeated experiments. 
To verify the staining results, we compared H3K9ac signal intensities by quantification 
between groups, indeed showing no alterations in H3K9ac by K9R mutation (Fig. 3.12), 
although lysine 9 on histone H3 is highly aggressively acetylated through replication and 
H3.1/2/3-GFPK9R mutants were proved to be clearly incorporated into the chromatin after 
microinjection. The results implied that mutation of K9R might cause the inability of histone 
H3 variants to get access to the acetylation-required areas but not to the non-acetylation 
related ones across the whole genome. 
 
Fig. 3.12 Quantification of H3K9ac signal normalized against Dapi signal in both parental genomes of 
zygotes expressing H3.1/2/3-GFPWT or K9R. Non-injected groups, grey; H3.1/2/3WT-GFP injected groups, 
dark green; H3.1/2/3K9R-GFP injected groups, light green; The quantified values in control group were set to 
1.Error bars indicated s.d.. For each group, at least 10 zygotes were analysed from at least two repeated 
experiments. 
3.1.8 Effects of H3.1/2/3-GFPK9R on 5mC and 5hmC   
Though only slight impacts on H3K9me2 were observed in all the injected groups, we still 
evaluated the influence of K9R mutation on the conversion of 5mC to 5hmC. However, no 
significant loss in 5mC was observed by immunostaining, which was further confirmed by 
quantification (Fig. 3.13 a, b, c, d). Correspondingly, 5hmC showed similar patterns between 
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groups (Fig. 3.13 e, f, g). We have to admit, that due to the technical problem related to 
mouse-derived anti-ssDNA antibody, we failed to quantify the signal intensity of 5hmC. 
 
 
 
Fig. 3.13 Influences on 5mC and 5hmC in zygotes expressing H3.1/2/3-GFPWT and K9R. a, b, c, 
Representative images of PN4/5 stage zygotes stained with antibodies against 5mC and DNA. 5mC, green; 
DNA, red. d, Quantification of 5mC signal normalized against DNA signal in both parental genomes of zygotes 
at PN4/5. Non-injected groups, grey; H3.1/2/3WT-GFP injected groups, dark green; H3.1/2/3K9R-GFP injected 
groups, light green; The quantified values in control group were set to 1. Error bars indicated s.d.. e, f, g, 
Representative images of PN4/5 stage zygotes stained with antibodies against 5mC and 5hmC. 5mC, green; 
5hmC, red. m, the maternal pronucleus; p, the paternal pronucleus; pb, polar body. For each group, at least 10 
zygotes were analysed from at least two repeated experiments.  
3.2 Effects of S10A and T11A mutations of H3.1/2/3-GFP on 
modifications of both histone and DNA in mouse zygotes 
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As the neighboring sites to lysine 9, serine 10 (S10) and threonine 11 (T11) could potentially 
be phosphorylated by different kinases (Hirota et al., 2005; Metzger et al., 2008). The 
growing evidence shows the crosstalks between K9 methylation (K9me), S10 phosphorylation 
(S10phos) and T11 phosphorylation (T11phos) (Baek, 2011; Fischle, 2008; Metzger et al., 
2008; Ng et al., 2007; Sabbattini et al., 2014), which prompted us to investigate the potential 
links among them.  
3.2.1 Dynamic patterns of H3S10phos and H3T11phos throughout the mouse 
zygotic stage  
First, we examined the dynamic patterns of phosphorylation at S10 and T11 on histone H3. 
As shown in Fig. 3.14a, H3S10phos was clearly detectable in G1 stage, was almost invisible 
during replication, and again appeared in G2 stage, which is in line with the published data 
(Ribeiro-Mason et al., 2012; Teperek-Tkacz et al., 2010). Notably, H3S10phos signal 
intensities were variable depending on the antibodies used. As for H3T11phos, it was absent 
in G1 stage, appeared from S phase on, and further accumulated in G2 phase (Fig. 3.14b). To 
our knowledge, it is the first description of H3T11phos pattern in mouse zygotes. Hence the 
two phosphorylation marks follow different dynamics during the first cell cycle. 
         
Fig. 3.14 Dynamic patterns of H3S10phos and H3T11phos in mouse zygotes. a, Representative images of 
zygotes at different PN stages stained with antibodies against H3S10phos. H3S10phos, red; Dapi, blue; b, 
Representative images of zygotes at different PN stages stained with antibodies against H3T11phos. H3T11phos, 
red; Dapi, blue; m, the maternal pronucleus; p, the paternal pronucleus; pb, polar body. For each group, at least 
10 zygotes were analysed from at least two repeated experiments. 
3.2.2 Effects of H3.1/2/3-GFPS10A on H3K9me2, 5mC and 5hmC 
To dissect the relations between H3S10phos, H3K9me2 and 5mC, we microinjected mRNAs 
encoding histone H3 variants, either WT or bearing S10A mutations, into early mouse zygotes 
(very critical: around 1 hour post fertilization). As shown in Fig. 3.15a and b, H3K9me2 was 
significantly reduced by around 30% in both H3.1-GFPS10A and H3.2-GFPS10A expressing 
zygotes, by around 15% in H3.3-GFPS10A expressing zygotes, when compared to the 
controls. Furthermore, the quantification results showed that 5mC was only impaired by 15% 
to 20% in the maternal genomes of H3.1-GFPS10A and H3.2-GFPS10A injected groups, 
while it remained comparable between H3.3-GFPS10A injected and non-injected control (Fig. 
3.15c and d), indicative of the weak but significant H3S10phos-switch role in maintaining 
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H3.1/2K9me2 and further protecting 5mC from being oxidized. Notably, the impact on 5mC 
is less than that on H3K9me2. Such discrepancies reflected that H3K9me2 and 5mC were 
hardly overlapped with each other in some certain regions. As expected, gain of 5hmC in the 
maternal pronucleus was observed in both H3.1-GFPS10A and H3.2-GFPS10A expressing 
groups (Fig. 3.15e). Intriguingly, despite of no alteration in 5mC, there seemed to be an 
observable increase of 5hmC in both parental genomes in H3.3-GFPS10A injected group 
(Fig. 3.15e), which is consistent with that in H3.3-GFPT11A injected group mentioned later. 
Collectively, H3.1/2/3S10phos served a weak protection for H3K9me2 in the maternal 
genome of mouse zygotes, of which H3.1 and H3.2 were related to the maintenance of 5mC 
to a low extent. Such low correlation could be explained by dephosphorylation of H3S10 
during replication, at the time when massive 5mC to 5hmC conversion was shown to take 
place (Wossidlo et al., 2011). Due to this reason, it was also hard to evaluate the effect of 
S10A mutation on H3S10phos in mouse zygotes. 
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Fig. 3.15 Influences on H3K9me2, 5mC and 5hmC in zygotes expressing H3.1/2/3-GFPS10A. a, c, e, 
Representative images of PN4/5 stage zygotes zygotes stained with antibodies against H3K9me2, 5mC and 
5hmC, respectively. H3K9me2, red; Dapi, blue; 5mC, green; DNA, red; 5hmC, red; m, the maternal pronucleus; 
p, the paternal pronucleus; pb, polar body. b, d, Quantification of H3K9me2 and 5mC signals normalized against 
Dapi and DNA signals in both parental genomes of zygotes at PN4/5, respectively. Non-injected groups, grey; 
H3.1/2/3-GFPS10A injected groups, green; The quantified values in control group were set to 1. Asterisks 
showed significant changes using Student’s t-tests (*=P<0.05, ***=P<0.001). Error bars indicated s.d. For each 
group, at least 10 zygotes were analysed from at least two repeated experiments. 
3.2.3 Effects of H3.1/2/3-GFPT11A on H3T11phos, H3K9me2, 5mC and 5hmC 
Next, we asked whether the appearance of H3T11phos during replication regulates the 
persistence of H3K9me2 on maternal chromosomes. First, to dissect the enrichment of 
threonine11 phosphorylation on all three histone variants, we therefore microinjected mRNAs 
encoding histone H3 variants (WT) or T11A mutations, respectively into early mouse 
zygotes. T11A mutation on H3.1 and H3.2 rather than on H3.3 resulted in dramatic loss in 
H3T11phos (Fig. 3.16a, b), suggesting that H3.1 and H3.2 but not H3.3 are the prime 
substrates for H3T11phos. Surprisingly, zygotes injected with H3.1-GFPWT and H3.2-
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GFPWT isoforms exhibited a variable but reproducible reduction in H3T11phos (Fig. 3.17a, 
b). This variable effect might be due to an altered abundance of free nuclear or cytoplasmic 
H3.1-GFPWT and H3.2-GFPWT that act as free substrates for H3T11 kinases, further 
impairing the H3T11phos antibody binding to the epitopes on the nucleosomes incorporated 
histones. To test this possibility, Triton treatment was introduced before fixation in 
immunostaining, which, theoretically, could wash away the same amount of free histones 
between groups from the zygotes. However, H3.1-GFPWT and H3.2-GFPWT injected groups 
still displayed higher background than other groups (Fig. 3.17c, d), which could be regarded 
as an artifact because of the existence of the zona pellucida (ZP). For this reason, it is hard to 
confirm because the Triton treatment can not be applied to zygotes without ZP. In zygotes 
injected with H3.3-GFPWT, in contrast, H3T11phos signals remained unchanged compared 
to non-injected controls (Fig. 3.17e), suggesting that H3T11phos is not linked to H3.3 
competition or incorporation into the chromatin.  
   
Fig. 3.16. Influences on H3T11phos in zygotes expressing H3.1/2/3-GFPT11A. a, Representative images of 
PN4/5 stage zygotes stained with antibodies against H3T11phos. H3T11phos, red; Dapi, blue. m, the maternal 
pronucleus; p, the paternal pronucleus; pb, polar body. b, Quantification of H3T11phos signal normalized 
against Dapi signal in both parental genomes of zygotes at PN4/5. Non-injected groups, grey; injected groups, 
green. The quantified values in control group were set to 1. Asterisks showed significant changes using Student’s 
t-tests (***=P<0.001). Error bars indicated s.d.. For each group, at least 10 zygotes were analysed from at least 
two repeated experiments. 
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Fig. 3.17 Influences on H3T11phos in zygotes expressing H3.1/2/3-GFPWT. a, b, e, Representative images 
of PN4/5 stage zygotes stained with antibodies against H3T11phos under PT condition. c, d, Representative 
images of PN4/5 stage zygotes stained with antibodies against H3T11phos under TP condition. H3T11phos, red; 
Dapi, blue. m, the maternal pronucleus; p, the paternal pronucleus; pb, polar body. For each group, at least 10 
zygotes were analysed from at least two repeated experiments.  
Next we analysed the effect of H3.1/2/3-GFPT11A overexpression on H3K9me2. We indeed 
observed a very strong and highly significant reduction of H3K9me2 in H3.1-GFPT11A and 
H3.2-GFPT11A injected zygotes, but in not H3.3-GFPT11A, in comparison to the non-
injected controls (Fig. 3.18a, b).  
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Fig. 3.18 Influences on H3K9me2 in zygotes expressing H3.1/2/3-GFPT11A. a, Representative images of 
PN4/5 stage zygotes stained with antibodies against H3K9me2. H3K9me2, red; Dapi, blue. m, the maternal 
pronucleus; p, the paternal pronucleus; pb, polar body. b, Quantification of H3Kme2 signal normalized against 
Dapi signal in both parental genomes of zygotes at PN4/5. Non-injected groups, grey; injected groups, green; 
The quantified values in control group were set to 1. Asterisks showed significant changes using Student’s t-tests 
(***=P<0.001). Error bars indicated s.d.. For each group, at least 10 zygotes were analysed from at least two 
repeated experiments. 
A possible explanation for this effect is that the T11A mutation influences the methylation 
and/or binding of anti-H3K9me2 antibody to its epitopes. To exclude the latter possibility, we 
therefore co-expressed H3.1-GFPT11A or H3.1-GFP together with the catalytical domain of 
G9a histone methyltransferase (G9aCat) in E.coli cells. The partially purified wild-type or 
mutated histones were probed by Western blot using the same anti-H3K9me2 antibody in IF 
immunostaining. As demonstrated on Supplementary Fig 4, the antibody clearly detects 
H3K9me2 on T11A mutated form (Fig. 3.19a, b). 
                    
Fig. 3.19 The effect of H3T11A mutation on H3K9me2 recognition by the specific antibody, used in this 
study, verified by Western blotting. a, Verification of expression of the recombinant histones by using 
antibody against histone H3. b, Verification of H3K9me2 presence on H3.1-GFPWT and T11A proteins. Lane 1, 
expression of H3.1-GFPWT alone as a negative control; Lane 2, coexpression of H3.1-GFPWT and G9aCat as a 
positive control; Lane3, coexpression of H3.1-GFPT11A and G9aCat; Lane 4, marker. 
Then we further detected the changes in 5mC and 5hmC, because H3K9me2 could serve as a 
protector against oxidation of 5mC to 5hmC in mouse zygotes according to the published data 
(Nakamura et al., 2012). Concomitant with the changes in H3K9me2 also DNA methylation 
(5mC) was strongly altered in the maternal pronuclei of H3.1/H3.2-GFPT11A expressing 
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zygotes (Fig. 3.20a and b). Correspondingly 5hmC signals were strongly enhanced in both 
H3.1-GFPT11A and H3.2-GFPT11A expressing groups compared to the controls (Fig. 3.20c). 
To our surprise, 5hmC signal was slightly decreased in the paternal pronuclei of either H3.1-
GFPT11A or H3.2-GFPT11A expressing zygotes, although 5mC and 5caC signals were 
comparable to those in the control group (Fig. 3.20a, b, c and d). Again despite of no 
significant change of 5mC in H3.3-GFPT11A injected zygotes, we observed an obvious 
increase of 5hmC in both parental genomes in H3.3-GFPT11A (and in the H3.3GFP1S10A) 
injected group not coupled to a significant reduction of 5mC (Fig. 3.20c). The mechanism 
responsible for the observed 5hmC fluctuation remains to be investigated in the future. Next 
we examined potential changes in DNA methylation by hairpin-bisulfite high-throughput 
sequencing of LINE1 repetitive elements. We only found a very minor reduction of fully 
methylated sites (CpG sites, methylated on both complementary DNA strands) in H3.1-
GFPT11A injected group compared to H3.1-GFPWT injected and non-injected groups (Fig. 
3.21). This indirectly supports the conclusion that most 5mC is converted to 5hmC – and both 
modifications are indistinguishable in bisulfite sequencing (Huang et al., 2010). However, we 
observed a significant increase in hemimethylated sites in the H3.1-GFPT11A expressing 
group (Fig. 3.21), suggesting that the increased level of 5hmC apparently affects the DNA 
methylation maintenance during replication. In summary, the introduction of mutated histone 
variants H3.1 and 3.2 at threonine 11 and, to minor extent at serine 10, has a strong influence 
on the presence of H3K9me2 in the maternal pronucleus and enhances the oxidation of 5mC 
to 5hmC. In contrast, the overrepresentation of H3.1T11A or H3.2-GFPT11A causes a partial 
loss of 5hmC in the paternal genome. 
            
Results 
 
41 
 
  
Fig. 3.20 Influences on 5mC, 5hmC and 5caC in zygotes expressing H3.1/2/3-GFPT11A. a, Representative 
images of PN4/5 stage zygotes stained with antibodies against 5mC and DNA. 5mC, green; DNA, red. b, 
Quantification of 5mC signal normalized against DNA signal in both parental genomes of zygotes at PN4/5. 
Non-injected groups, grey; injected groups, green; The quantified values in control group were set to 1. Asterisks 
showed significant changes using Student’s t-tests (**=P<0.01, ***=P<0.001). Error bars indicated s.d.. c, 
Representative images of PN4/5 stage zygotes stained with antibodies against 5hmC and 5mC. 5hmC, red; 5mC, 
green; h, Representative images of PN4/5 stage zygotes stained with antibodies against 5caC and 5mC. 5caC, 
red; 5mC, green. m, the maternal pronucleus; p, the paternal pronucleus; pb, polar body. For each group, at least 
10 zygotes were analysed from at least two repeated experiments. 
 
Fig. 3.21 Methylation patterns of LINE1 repetitive element in non-injected, H3.1-GFPWT injected and 
H3.1-GFPT11A injected groups. The bars represented the DNA methylation status of all CpG dyads. The maps 
beside the bars showed the distribution of methylated sites. Columns and lines stand for CpG sites and sequence 
reads, respectively. Red, fully methylated CpG dyads; light green and dark green, hemi-mCpG dyads on the 
upper and lower strand; blue, unmethylated CpG dyads; white, mutated or not analysable.  
3.3 Introduction of H3K9me2 into the paternal chromatin of mouse 
zygotes by G9aFL-GFP and G9aCat-NLS-GFP  
It was demonstrated that H3K9me2 contributes to maintenance of 5mC in the maternal 
genome as well as at some loci in the paternal one (Nakamura et al., 2012) and that H3K9me2 
has an asymmetrical distribution pattern in parental genomes, being much more abundant in 
the maternal pronucleus and nearly undetectable in the paternal one (Lepikhov and Walter, 
2004; Liu et al., 2004; Santos et al., 2005). Currently, the absence of H3K9me2 in the paternal 
chromatin is viewed as a main reason for the dominant occurrence of DNA demethylation of 
the paternal genome in mouse zygotes. Here, we investigated that whether the discrepancy in 
DNA methylation is really caused by the asymmetry of H3K9me2 between the parental 
genomes or not. Futhermore, we evaluted the contribution of H3 variants to the DNA 
methylation reprogramming. 
3.3.1 Effects on H3K9me2  
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To challenge this assumption and to boost H3K9me2 in mouse zygotes artificially, G9a (also 
known as EHMT2), an H3K9me2-specific histone methyltransferase, was considered as a 
promising candidate to be employed. First, we examined the distribution of endogenous G9a 
by immunostaining, which showed that G9a was totally absent from the pronuclei in the 
zygotic stage, seemed to be rather sparsely distributed in the nuclei in the 2-cell stage and 
began to accumulate in the nucleus from 4-cell stage on (Fig. 3.22), in agreement with the 
published data (Li et al., 2013).  
 
Fig. 3.22 Dynamic patterns of G9a during mouse preimplantation development. Representative images of 
different staged embryos stained with antibodies against G9a. G9a, red; Dapi, blue; m, the maternal pronucleus; 
p, the paternal pronucleus; pb, polar body. For each group, at least 10 zygotes were analysed from at least two 
repeated experiments. 
Then we ectopically expressed G9a in early mouse zygotes (around 1 hpf). When expressing a 
full length GFP tagged G9a version (G9aFL-GFP) we only found a minor effect on H3K9me2 
(Fig. 3.23). The N-terminus of G9A apparently interferes with its function in the zygote - a 
finding that is in agreement with the observation that the oocyte triggers a mechanism 
suppressing G9a function (Liu et al., 2004). The injection of a shorter G9aCat-NLS-GFP 
version (G9a catalytical domain fused with NLS of SV40 and GFP) overcame these 
restrictions and efficiently enhanced the H3K9me2 (Fig. 3.23). Meanwhile, H3K9me3 was 
also evaluated in order to confirm the specificity of G9a (Fig. 3.24). It is noteworthy that the 
observed effects were also strictly associated with time point of microinjection (the injection 
should take place within 1.5hpf).  
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Fig. 3.23 Introduction of H3K9me2 into both genomes of mouse zygotes by ectopically expressed G9aFL-
GFP and G9aCat-NLS-GFP. a, Representative images of PN4/5 stage zygotes stained with antibodies against 
H3K9me2. H3K9me2, red; Dapi, blue. m, the maternal pronucleus; p, the paternal pronucleus; pb, polar body. b, 
Quantification of H3Kme2 signal normalized against Dapi signal in both parental genomes of zygotes at PN4/5. 
Non-injected groups, grey; injected groups, green; The quantified values in control group were set to 1. Asterisks 
showed significant changes using Student’s t-tests (***=P<0.001). Error bars indicated s.d.. For each group, at 
least 10 zygotes were analysed from at least two repeated experiments. 
 
Fig. 3.24 No influences on H3K9me3 in mouse zygotes expressing G9aFL-GFP and G9aCat-NLS-GFP. 
Representative images of PN4/5 stage zygotes stained with antibodies against H3K9me3. H3K9me3, red; Dapi, 
blue. m, the maternal pronucleus; p, the paternal pronucleus; pb, polar body. For each group, at least 10 zygotes 
were analysed from at least two repeated experiments. 
3.3.2 Effects on 5mC and 5hmC  
Since a dramatic increase of H3K9me2 appeared in both pronuclei of mouse zygotes 
expressing G9aCat-NLS-GFP, we further checked the changes in 5mC and 5hmC by 
immunostaining. Very surprisingly, the signal intensities of 5mC and 5hmC were comparable 
in both parental genomes between injected and noninjected groups (Fig. 3.25a, c), suggesting 
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that artificial introduction of H3K9me2 failed to block active DNA demethylation (5mC to 
5hmC conversion) in the paternal genome on a global scale. However, through quantification, 
a minor but significant increase of 5mC was found in both parental genomes of mouse 
zygotes expressing G9aCat-NLS-GFP (Fig. 3.25b), indicating that a small amount of 5mC 
was indeed protected from being oxidated by the acquisition of H3K9me2. In contrast, in 
G9aFL-GFP injected zygotes, only rather small amount of 5mC was rescued after 
introduction of H3K9me2 in the paternal genome (Fig. 3.25b). Notably, this small fraction of 
5mC rescued by the reacquisition of H3K9me2 in both parental genomes on one hand 
confirmed the protection role of H3K9me2 in 5mC and, on the other hand, may reflect the 
passive dilution mechanism in which the replication-dependent loss of H3K9me2 could lead 
to the exposure of 5mC to Tet3 dioxygenase. 
            
 
Fig. 3.25 Influences of G9aFL-GFP and G9aCat-NLS-GFP expression in zygotes on 5mC and 5hmC. a, 
Representative images of PN4/5 stage zygotes stained with antibodies against 5mC and DNA. 5mC, green; 
DNA, red. b, Quantification of 5mC signal normalized against DNA signal in both parental genomes of zygotes 
at PN4/5. Non-injected groups, grey; injected groups, green; The quantified values in control group were set to 1. 
Asterisks showed significant changes using Student’s t-tests (***=P<0.001). Error bars indicated s.d..c, 
Representative images of PN4/5 stage zygotes stained with antibodies against 5mC and 5hmC. 5mC, green; 
5hmC, red. m, the paternal pronuclei; p, the paternal pronuclei; pb, polar body. For each group, at least 10 
zygotes were analysed from at least two repeated experiments. 
Subsequently, the methylation levels on three repetitive elements, including long interspersed 
elements (LINE1), intracisternal A-particle element (IAP) and major satellites (mSat) were 
evaluated in G9aCat-NLS-GFP injected zygotes by the hairpin bisulfite sequencing. As a 
result, the methylation heatmaps displayed the similar patterns between groups (Fig. 3.26), 
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further confirming the immunostaining results that active DNA demethylation was not 
globally affected given the fact that these three repetitive elements have a rather broad 
distribution across the whole genome.   
 
Fig. 3.26 Methylation patterns of repetitive elements in G9aCat-NLS-GFP injected and non-injected 
groups. The bars represented the DNA methylation status of all CpG dyads. The maps beside the bars showed 
the distribution of methylated sites. Column and line standed for CpG sites and sequence read, respectively. Red, 
fully methylated CpG dyads; light green and dark green, hemi-mCpG dyads on the upper and lower strand; blue, 
unmethylated CpG dyads; white, mutated or not analysable.  
3.4 Dissecting relations between H3K9me2 and histone H3.1/2/3 by 
co-injection of G9aCat-NLS-GFP and H3.1/2/3-GFPT11A 
The failure to arrest oxidation of 5mC to 5hmC in the paternal genome on a global level by 
introduction of H3K9me2 strongly indicates the differences in chromatin structure and DNA 
methylation distribution between male and female pronuclei. One explanation could be that 
the regions artificially covered with H3K9me2 by G9aCat-NLS-GFP are rather sparsely 
enriched with 5mC. Hence, it is necessary to address the question that which histone H3 
variants could be linked to the 5mC-poor regions in the paternal genome of mouse zygotes, 
which will help us to locate the main player (H3.3?) related to the active DNA demethylation 
by excluding the unrelated ones (H3.1 and/or H3.2?). So far, we have already demonstrated 
that T11A mutation on H3.1 and H3.2, but not on H3.3, abolished H3K9me2 in the maternal 
genome of mouse zygotes. In addition, it must be mentioned that G9a could target and 
methylate the histone H3 as a substrate even including T11A mutant form, which has been 
demonstrated by in vitro assay (Chin et al., 2005) and our Western blotting results (Fig. 3.19). 
Therefore, by taking advantage of this protection mechanism that T11A mutation could 
negatively interfere with H3K9me2-specific methylation activity, we performed coinjection 
of G9aCat-NLS-GFP and H3.1-GFPT11A or H3.2-GFPT11A or H3.3-GFPT11A, which 
makes it possible to uncover the potential links between histone variants, H3K9me2 and 5mC.  
3.4.1 Effects on H3K9me2  
As a result, H3K9me2 dramatically decreased in both pronuclei by co-injection of G9aCat-
NLS-GFP either with H3.1-GFPT11A or with H3.2-GFPT11A. At the same time, the 
dramatic enhancement of H3K9me2 in both pronuclei, caused by G9aCat-NLS-GFP (Fig. 
3.27a, b), was not affected by H3.3-GFPT11A co-expression (Fig. 3.27a, b). The signal 
intensity was similar to that in zygotes expressing G9aCat-NLS-GFP alone (Fig. 3.23a, b). 
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This result clearly indicates that H3.1 and H3.2, but not H3.3, served as the substrates for 
G9aCat-NLS-GFP. Therefore, H3.1 and H3.2, which loose K9me2 during replication, are 
involved in passive DNA demethylation in both parental genomes. Also indirectly, it implies 
that H3.3 could be a promising player linked to global active DNA demethylation in mouse 
zygotes. 
   
Fig. 3.27 Ablation of H3K9me2 by co-injection of G9aCat-NLS-GFP with H3.1-GFPT11A or H3.2-
GFPT11A, respectively. a, Representative images of PN4/5 stage zygotes stained with antibodies against 
H3K9me2. H3K9me2, red; Dapi, blue. m, the maternal pronucleus; p, the paternal pronucleus; pb, polar body. b, 
Quantification of H3Kme2 signal normalized against Dapi signal in both parental genomes of zygotes at PN4/5. 
Non-injected groups, grey; injected groups, green; The quantified values in control group were set to 1. Asterisks 
showed significant changes using Student’s t-tests (***=P<0.001). Error bars indicated s.d.. For each group, at 
least 10 zygotes were analysed from at least two repeated experiments. 
3.5 Microinjection of H3.3-GFPK9me2 proteins 
As shown above, H3.1 and H3.2 were not responsible for the major loss of DNA methylation 
in the paternal genome of mouse zygotes, this prompted us to verify the hypothesis that H3.3 
would be a potential major player involving in global active DNA demethylation, as 
suggested by many groups based on the fact that H3.3 is preferentially located in male 
pronucleus before and during DNA replication (Torres-Padilla et al., 2006; van der Heijden et 
al., 2005; Wu and Zhang, 2010). 
3.5.1 Localization of purified proteins of H3.3-GFPK9me2   
To test this hypothesis, we decided to microinject the premodified H3.3-GFPK9me2 proteins 
into early mouse zygotes, which may have the chance to block the active DNA demethylation 
pathway to some degree. First, we coexpressed G9aCat and H3.3-GFP or expressed H3.3-
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GFP just alone in Rosetta™ 2 E.coli cells. Western blot analysis of thus produced 
recombinant histone H3.3-GFP protein has shown, that dimethylation but not trimethylation 
was successfully introduced onto K9 residue (Fig. 3.28a, b, c).  
 
Fig. 3.28 Western blotting detection of H3.3-GFPK9me2 (modified) and H3.3-GFP (unmodified) proteins 
after purification. a, Verification of purification of H3.3-GFPK9me2 and H3.3-GFP by using antibody against 
GFP. Lane1, marker; lane 2, H3.3-GFPK9me2 protein; lane 3, H3.3-GFP protein. b, c, Verification of 
dimethylation and trimethylation at lysine 9 of H3.3-GFP and H3.3-GFP by using antibodies against H3K9me2 
and H3K9me3, respectively. Lane1, H3.3-GFPK9me2 protein; marker; lane 2, H3.3-GFP protein; lane 3, 
marker. 
Then, protein purification was performed, which was followed by dialysis. In the end, 
modified H3.3-GFPK9me2 and unmodified proteins were microinjected into very early 
zygotes (around 1-1.5hpf), respectively. Surprisingly, H3.3-GFPK9me2 protein failed to enter 
into both pronuclei compared to H3.3-GFPWT (Fig. 3.29), indicating that the site K9 may be 
very crucial for nuclear trafficking of histone H3.3 or that at least dimethylation on K9 should 
be avoided before deposition into the chromatin, which was to some extent in line with the 
published data that K9 of histone H3 is essential for histone incorporation across some species 
(Kuo et al., 1996; Sobel et al., 1995; Turner and O'Neill, 1995). It is noteworthy that this view 
was also supported by our H3.1/2/3-GFPK9R mutation data that none of the histone H3 
variants could affect H3K9ac level in both pronuclei (Fig. 3.11 and 3.12), although H3K9ac 
exhibited a dramatic increase through replication in mouse zygotic stage (Fig. 3.3). 
Additionally, due to its inability to deposit into the chromatin, H3.3-GFPK9me2 protein 
seemed to be cleared away via degradation, because the GFP signal vanished in a few hours 
after microinjection. Therefore, practically, it is not feasible to impede global active DNA 
demethylation by microinjection of premodified H3.3-GFPK9me2 protein.  
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Fig. 3.29 Localization of H3.3-GFPK9me2 and WT proteins. H3.3-GFPWT showed a clear nuclear 
localization by GFP signals. As for the H3.3-GFPK9me2 protein, it failed to enter both pronuclei and showed 
gradual degradation in the cytoplasm. And fertilization was verified by Dapi staining in the H3.3-GFPK9me2 
injected group. GFP, green; Rhodamine dextran tracer, red. Dapi, blue. For each group, at least 10 zygotes were 
analysed from at least two repeated experiments. 
3.6 Relation between H3K9ac and DNA methylation 
As an active transcription marker, H3.3 is claimed to be highly correlated with H3K9ac across 
the species (Ahmad and Henikoff, 2002; Loyola and Almouzni, 2007). Meanwhile, given the 
potential critical role of preacetylation at K9 in histone H3.3 for the deposition into the 
chromatin, we speculate that, the failure of G9aCat-NLS-GFP to modify H3.3 was due to the 
pre-occupancy of K9 residue with acetyl group. Indeed, our result showed that H3K9ac was 
not altered by the ectopic expression of G9aCat-NLS-GFP (Supplementary Fig. 6). In that 
case, removal of acetyl group from K9 on H3.3 seems to be a necessary step for creating an 
ideal substrate for G9aCat-NLS-GFP in mouse zygotes.   
3.6.1 Effect on DNA methylation by loss of H3K9ac  
Before introducing a dimethyl group to K9 site on H3.3, we first performed the evaluation on 
the DNA methylation changes by abolishing H3K9ac. By microinjection of mRNAs, 
encoding histone deacetylases HDAC1-GFP and/or HDAC2-GFP into early zygotes, we 
successfully released acetyl groups from K9 sites of histone H3. As shown in Fig. 3.30, a 
great loss of H3K9ac was observed in injected groups compared to non-injected ones. The 
efficiencies between HDAC1-GFP, HDAC2-GFP and combination of these two were rather 
similar (Fig. 3.30). Moreover, the decrease of H3K9ac by HDAC1-GFP did not cause any 
increase of K9me2 (Fig. 3.31d). This finding supports the notion that indeed H3.3 is the main 
target of H3K9ac. Furthermore, we examined the changes in 5mC as well as 5hmC in 
HDAC1-GFP injected zygotes. Nevertheless, the dramatic reduction in H3K9ac was not 
accompanied with any changes in 5mC as well as 5hmC (Fig. 3.31a, b, c), suggesting that 
H3K9ac was not required for global active DNA demethylation in the paternal genome of 
mouse zygotes.   
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Fig. 3.30 Influences on H3K9ac in zygotes expressing HDAC1-GFP, HDAC2-GFP and their combination, 
respectively. a, Representative images of PN4/5 stage zygotes stained with antibodies against H3K9ac. H3K9ac, 
red; Dapi, blue; m, the maternal pronucleus; p, the paternal pronucleus; pb, polar body. b, Quantification of 
H3K9ac signal normalized against Dapi in both parental genomes of zygotes at PN4/5. Non-injected groups, 
grey; HDACs-GFP injected groups, green; The quantified values in control group were set to 1. Asterisks 
showed significant changes using Student’s t-tests (***=P<0.001). Error bars indicated s.d.. For each group, at 
least 10 zygotes were analysed from at least two repeated experiments. 
       
       
Fig. 3.31 Influences on 5mC and 5hmC in zygotes expressing HDAC1-GFP. a, Representative images of 
PN4/5 stage zygotes stained with antibodies against 5mC and DNA. 5mC, green; DNA, red; b, Quantification of 
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5mC signal normalized against DNA signal in both parental genomes of zygotes at PN4/5. Non-injected group, 
grey; HDAC1-GFP injected group, green; The quantified values in control group were set to 1. Asterisks showed 
significant changes using Student’s t-tests (***=P<0.001). Error bars indicated s.d.. c, Representative images of 
PN4/5 stage zygotes stained with antibodies against 5hmC and 5mC. 5hmC, red; 5mC, green. d, Representative 
images of PN4/5 stage zygotes stained with antibodies against H3K9me2. H3K9me2, red; Dapi, blue. m, the 
maternal pronucleus; p, the paternal pronucleus; pb, polar body. For each group, at least 10 zygotes were 
analysed from at least two repeated experiments. 
3.6.2 Effect on H3K9me2 by co-injection of G9aCat-NLS-GFP and HDAC1-
GFP  
The efficient removal of H3K9ac by HDAC1-GFP means that more vacant K9 sites could 
appear across the chromatin and serve as the substrates for G9aCat-NLS-GFP. Based on this, 
subsequently, we performed the co-injection of G9aCat-NLS-GFP and HDAC1-GFP in order 
to modify the free K9 sites into the dimethylation form. Theoretically, more H3K9me2 signal 
would emerge in co-injected zygotes. However, unfortunately, the immunostaining showed 
rather comparable signal intensites of H3K9me2 between co-injected zygotes and G9aCat-
NLS-GFP alone injected ones (Fig. 3.32), indicating that dimethyl groups were not 
successfully transferred to the deacetylated K9 sites.  
   
Fig. 3.32 Influences on H3K9me2 in zygotes expressing both HDAC1-GFP and G9aCat-NLS-GFP. a, 
Representative images of PN4/5 stage zygotes stained with antibodies against H3K9me2. H3K9me2, red; Dapi, 
blue. m, the maternal pronucleus; p, the paternal pronucleus; pb, polar body. b, Quantification of H3Kme2 signal 
normalized against Dapi signal in both parental genomes of zygotes at PN4/5. Non-injected groups, grey; 
injected groups, green; The quantified values in control group were set to 1. Asterisks showed significant 
changes using Student’s t-tests (***=P<0.001). Error bars indicated s.d.. For each group, at least 10 zygotes were 
analysed from at least two repeated experiments. 
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4 Discussion 
In mouse zygotes, reprogramming is triggered upon the fusion of oocyte and sperm, which is 
characterized by chromatin reorganization and DNA demthylation (Burton and Torres-
Padilla, 2014; Reik et al., 2001; Wu and Zhang, 2010). Traditionally, on one hand, it has been 
viewed that DNA demethylation occurs only in the paternal genome in mouse based on 
immunofluorescence staining of 5mC (Mayer et al., 2000; Oswald et al., 2000), which is later 
proved to be a Tet3-related iterative oxidation to 5hmC, further to 5fC and 5caC (He et al., 
2011; Inoue et al., 2011; Iqbal et al., 2011; Ito et al., 2011; Wossidlo et al., 2011). Most 
recently, it is clearly demonstrated on the molecular level that both the maternal and the 
paternal genomes undergo DNA demethylation in a combination manner of replication-
dependent dilution and Tet3-based oxidation (Arand et al., 2015; Guo et al., 2014b; Shen et 
al., 2014). On the other hand, it is assumed that H3K9me2 could be the major player 
involving in maintenance of 5mC in the maternal genome, since it displays a rather dominant 
distribution in female pronucleus (Lepikhov and Walter, 2004; Liu et al., 2004; Santos et al., 
2005) and a number of evidence demonstrates the interplay between H3K9me2 and 5mC 
across species (Bernatavichute et al., 2008; Jackson et al., 2004; Tamaru and Selker, 2001). 
Furthermore, recently Nakamura et al. have confirmed that H3K9me2, together with PGC7, 
indeed is responsible for preventing oxidation of 5mC in the maternal genome, as well as 
some loci in the paternal one (Nakamura et al., 2007; Nakamura et al., 2012). However, 
because of the existence of histone H3 variants, namely H3.1, H3.2 and H3.3 (Hake and Allis, 
2006; Kamakaka and Biggins, 2005; Loyola and Almouzni, 2007), on each of which lysine 9 
could be theoretically modified to be a dimethylated form, it is necessary to dissect the 
relation between H3K9me2 and histone H3 variants, which could further clarify the roles of 
histone H3 variants in embryonic reprogramming. According to the literature, H3K9me2 is 
regarded to be enriched on H3.1 or H3.2 but not H3.3 (Loyola and Almouzni, 2007), which 
raises the question that whether it is true in mouse zygotes and how the differences in 
H3K9me2 on histone H3 variants are caused or regulated. The exploration of this regulation 
pathway for H3K9me2 will definitely help us gain a better understanding of the distinctive 
chromatin structures and DNA methylation patterns between the maternal and the paternal 
pronuclei. Here, in this work, we show that it is primarily histone H3.1 and secondarily H3.2 
that carry K9me2 to impede oxidation of 5mC into 5hmC in an H3T11phos dependent 
manner on a global level in the maternal genome of moues zygotes. Furthermore, we reveal 
that H3.1 and H3.2, which are lack of H3K9me2 during replication, are responsible for the 
dilution-dependent passive DNA demethylation on a small scale in both parental genomes. 
Last but not least important, we conclude that H3.3 escapes from being dimethylated at K9 by 
the endogenous histone methyltransferases due to the presence of H3K9ac and the absence of 
H3T11phos, which ensures the proper occurrence of active DNA demethylation on a 
relatively global level in both male and female genomes of mouse zygotes. Taken togther, the 
regulatory mechanism may also shed a light upon reprogramming in stem cells, induced 
pluripotent cells as well as somatic cell nuclear cloning.     
4.1 Inefficient disruption in H3K9me2/me3/ac by H3.1/2/3-GFPK9R 
in both parental genomes of mouse zygotes 
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As early as 2004, Liu et al. have proposed a model that H3K9me2 and H3K9me3 are diluted 
in a replication-dependent manner during mouse zygotic stage (Liu et al., 2004), which is 
confirmed by our observation. However, our experiments by microinjection of H3.1/2/3-
GFPK9R mRNAs demonstrate that it is not a simple dilution model but rather a complicated 
one involving remethylation activities for both H3K9me2 and H3K9me3, consistent with the 
previous data that de novo H3K9me2 has been detected in the paternal genome of mouse 
zygotes (Santos et al., 2005). As a specific histone methyltransferase for H3K9me2, G9a, 
could be a promising candidate for remethylation process. However, it is not the case in 
mouse zygote, because the application of Bix 01294 (a specific inhibitor against G9a) to 
mouse zygotes failed to bring about any changes in H3K9me2 (Supplementary Fig. 1), 
indicative of the the presence of an active G9a suppressing mechanism, triggered by oocyte 
activation, which was proposed by Liu et al (Liu et al., 2004). Alternatively, it may be due to 
the absence of G9a in mouse zygotes, in line with our data and the published ones that G9a is 
undetectable on both protein and mRNA levels in mouse zygotic stage (Fig. 3.21) (Kageyama 
et al., 2007; Li et al., 2013). For the other potential histone methyltransferases involved in 
histone remethylation, Suv39h2, mainly responsible for H3K9me3, could be one of the 
players owing to the presence of its mRNA in mouse zygotes (Kageyama et al., 2007; 
Schuhmacher et al., 2015). Also indeed, when applying Chaetocin at a very low concentration 
in mouse zygotes, which is supposed to be specifically inhibit SU(VAR)3-9 (Greiner et al., 
2005), we observe the severe changes in H3K9me3, reorganization of heterochromatin as well 
as nuclear topology (supplementary Fig. 2), in line with the published data (Zinner, 2007). 
How this dynamic turnover of demethylation (either active or passive) and remethylation at 
K9 on histone H3 variants is achieved and why remain to be investigated in the future.  
Next, we dissect the distribution of H3K9me2 among histone H3 variants. All three 
histone H3-GFPK9R mutants cause slight decrease of H3K9me2 in the maternal pronucleus, 
while only K9R mutants of H3.2 and H3.3 lead to reduction in H3K9me2 in the paternal 
genomes, reflecting the differences in distribution of H3K9me2 on histone H3 variants 
between the female and male genomes. As for H3K9me3, it is enriched on H3.1 and H3.2 but 
not on H3.3 in the maternal genome. Generally speaking, as repressive marks, both H3K9me2 
and H3K9me3 are mostly related to H3.1 and H3.2, which is in line with the literature that 
H3.1and H3.2 are responsible for the formation of constitutive and facultative 
heterochromatin characterized by H3K9me2 and H3K9me3 (Hake and Allis, 2006; Jacob et 
al., 2014). Additionally, regarding H3.3, its link to repressive mark H3K9me2 shown by 
quantification is not so surprising, because some groups have claimed its passive role in 
specific local regions (Goldberg et al., 2010; Schwartz and Ahmad, 2006; Szenker et al., 
2011), although typically it serves as an active mark (Hake and Allis, 2006; Loyola and 
Almouzni, 2007).    
Despite the minor but significant reduction in H3K9me2, no obvious loss in 5mC is 
observed. On one hand, these two marks may not be overlapped with each other in some 
certain local regions. On the other hand, the loss in 5mC may be compensated to a small 
degree by de novo methylation occurring on umethylated K4 of newly transcribed exogenous 
histone H3, based on the reportes that unmethylated H3K4 could be well recognized by 
DNMT3A–DNMT3L complex both in vivo and in vitro, respectively, further leading to de 
novo methylation ((Hashimoto et al., 2010; Hu et al., 2009; Ooi et al., 2007; Otani et al., 
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2009; Zhang et al., 2010). Notably, both Dnmt3A and Dnmt3L are located in the parental 
pronuclei in mouse zygotes (Gu et al., 2011; Hirasawa et al., 2008), which make this 
hypothesis theoretically possible.  
Concerning the slight impacts on H3K9me2 as well as H3K9me3 by H3.1/2/3-
GFPK9R mutants, it could be attributed to the rather low efficiency in randomly replacing old 
histone H3 carrying H3K9me2 by the K9R mutants in mouse zygotes, most probably because 
the old methylated histone H3 always exists in the form of a dimer with H4 in the cytoplasm 
and is prepared for the new assembly of a tetramer, further for an octamer before deposition 
into the chromatin during DNA replication (Tagami et al., 2004), leaving rather limited 
chance for newly synthesized monomer of histone H3K9R mutants to substitute for the old 
histone H3.  
In contrast to H3K9me2/3, H3K9ac is progressively accumulated in both pronuclei 
through DNA replication. Nevertheless, no reduction in H3K9ac is caused by any of 
H3.1/2/3-GFPK9R mutants, indicating that the mutants fail to target to the H3K9ac-
demanding areas,  although they succeed to impair the other regions requring H3K9me2 or 
me3 in an inefficient manner as shown above, which to some extent points out the possible 
role of K9 in determining the histone deposition into the certain chromatin regions. Also, this 
potential view is supported by our experiment that in vitro modified H3.3-GFPK9me2 protein 
loses the ability to be transported into both pronuclei in mouse zygotes. According to the 
literature, it has been demonstrated in some other species that pre-acetylation on K9 of histone 
H3 is essential for its incorporation into chromatin (Kuo et al., 1996; Sobel et al., 1995; 
Turner and O'Neill, 1995), suggesting that the rule seems to be evolutionarily conserved, at 
least in mice. Since K9ac is closely associated with H3.3 (Hake and Allis, 2006; Loyola and 
Almouzni, 2007), we speculate that this preacetylation step at K9 may be specific to H3.3 but 
not H3.1 and H3.2.    
4.2 Phosphorylation on H3.1/2S10 and H3.1/2T11 serving as a double 
switch for H3K9me2 in the maternal genome of mouse zygotes  
According to the literature, the crosstalks among these three neighboring sites, lysine 9 (K9), 
serine 10 (S10) and threonine 11 (T11), on histone H3 have been illustrated (Baek, 2011; 
Fischle, 2008; Sabbattini et al., 2014). Typically, it refers to the interaction between 
methylation on K9 and phosphorylation on either S10 or T11 or both. Since these 
modifications could be theoretically applied onto each of histone H3 variants (H3.1, H3.2 or 
H3.3) in a cell cycle-dependent or independent manner, the crosstalks among them become 
spatially and temporally dynamic. Furthermore, given the established link between H3K9me2 
and 5mC in the maternal genome of mouse zygotes (Nakamura et al., 2012), whether 
H3S10phos and H3T11phos play any roles in this pathway is rather intriguing. Here, in our 
study, we demonstrate that H3.1/2S10phos and H3.1/2T11phos offer a protection for 
H3K9me2, further contributing to the maintenance of 5mC. In contrast, H3.3, which is not 
related to H3T11phos, is not responsible for the maintenance of 5mC in the maternal genome, 
implying that it may be involved in active DNA demethylation. 
Regarding the protection of H3S10phos for H3K9me2, it is conceivable from the 
published data that S10phos on H3 could prevent K9 from being targeted by either antibodies 
or histone methyltransferases (Duan et al., 2008; Jeong et al., 2010). However, owing to the 
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dephosphorylation on S10 from G1 to S phase in mouse zygotes (Ribeiro-Mason et al., 2012; 
Teperek-Tkacz et al., 2010), the protection effect from S10phos on K9 is gradually becoming 
weak. Also, due to the same reason, it is not easy to evaluate the effects of H3.1/2/3-
GFPS10A mutants on S10phos in mouse zygotes. It must be mentioned that the extent of 
dephosphorylation on S10 in mouse zygotes is observed to be variable depending on the 
antibodies based on our experiments and the published data (Ribeiro-Mason et al., 2012; 
Teperek-Tkacz et al., 2010). Additionally, the differences from H3.1, H3.2 and H3.3 in 
contribution to the shielding for H3K9me2 (30%, 30% and 15%, respectively) again confirm 
that H3.1 and H3.2 are highly enriched with H3K9me2. Besides, by further comparison with 
the amount of loss in 5mC by H3.1, H3.2 and H3.3 (15%, 15% and 0%), it clearly shows that 
the loss in H3K9me2 does not correspond to the equal amount of reduction in 5mC. Such 
discrepancy reflects that indeed some H3K9me2-rich regions are hardly overlapped by 5mC, 
which is consistent with the results aforementioned. However, we can not rule out the 
possibility that this observation can also potentially be due to different performance of 
H3K9me2 and 5mC antibodies.       
As for H3T11phos, its dynamics in mouse zygotes has not been documented before. 
To our knowledge, in our study, it is the first time for description of this histone mark in 
mouse zygotes. Generally, concomitant with the disappearance of H3S10phos, H3T11phos is 
dramatically accumulated from DNA replication on (Supplementary Fig. 3), in which H3.1 
and H3.2 are involved equally, while H3.3 is not phosphorylated. Moreover, the loss of 
H3K9me2 triggered by reduction in H3T11phos by either H3.1-GFPT11A or H3.2-GFPT11A 
clearly demonstrates a cross talk between these two histone marks, which is similar to an in 
vitro experiment that demethylation of K9me3 on the H3 peptide by KDM4A and KDM4C is 
blocked when T11 is phosphorylated (Lohse et al., 2013). However, another group has 
reported an opposite in vitro observation that the removal of H3K9me3 by KDM4C is 
accelerated by H3T11phos (Metzger et al., 2008). These two inverse results may be ascribed 
to the different reaction systems, for both experiments are performed in vitro. At least, we 
have shown this protection role of H3T11phos in H3K9me2, to a certain extent, suggesting 
the existence of active endogenous histone demethylases in mouse zygotes. Whether it is 
conserved or not in other species should be checked. Meanwhile, notably, H3.1-GFPT11A 
causes much more changes in H3K9me2 in both female and male pronuclei than H3.2-
GFPT11A, indicating that H3.1 is the main carrier for H3K9me2. Subsequently, the further 
detection of both 5mC and 5hmC, with H3.1-GFPT11A injected group showing a more 
prominent abolishment of 5mC in the maternal genome compared to H3.2-GFPT11A injected 
group, strongly demonstrates that it is mainly H3.1T11phos that protects H3.1K9me2 from 
endogenous histone demethylase, further impeding the conversion of 5mC to 5hmC in the 
maternal genome. Rather interestingly, in the paternal genome, although no changes in 5mC 
are caused by either H3.1-GFPT11A or H3.2-GFPT11A, 5hmC levels appear to descend 
based on the signal intensities from IF-experiment, suggesting that it might be the case that 
T11A or other potential modifications interfere with the iterative oxidation of 5hmC to 5fC 
and 5caC. However, rather than blocking of the oxidation pathway, it seems that the other 
pathways may participate, for 5caC intensity in H3.1-GFPT11A expressing zygotes remains 
relatively equal compared to the control, although fC data are missing here. Notably, in H3.3-
GFPT11A injected group, 5hmC seemed to be increased in both parental genomes to some 
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extent without influencing 5mC, similar to that in H3.3-GFPS10A injected group. Generally 
speaking, on the level of 5hmC, it appears to be fluctuating depending on histone H3 variants. 
One possible assumption behind is that another Tet-related pathway may be influenced either 
negatively or positively, in which, rather than phosphorylation, the O-linked N-
acetylglucosamine transferase (OGT) mediated glycosylation on either serine 10 or threonine 
11 may be interfered, since OGT is reported to interact with all Tets proteins and to be 
essential for mouse embryogenesis (Deplus et al., 2013; Shi et al., 2013; Vella et al., 2013). It 
is concievable that competition between phosphorylation and glycosylation on H3T11 may 
determine the fate of downstream modifications such as H3K9me2 as well as 5mC. Besides, 
by comparing the efficiency between H3.1/2-GFPK9R and H3.1/2-GFPT11A in affecting 
H3K9me2 (minor versus dramatic), we assume that the crosstalk between H3K9me2 and 
H3T11phos may occur between the distinct copies of histone H3 within the same nucleosome 
or between the neighboring nucleosomes spatially close to each other. 
In summary, it is phosphorylation on threonine (T) rather than on serine (S) of H3.1/2 
that serves as a dominant protection layer for K9me2, which further prevents 5mC from 
demethylation in the maternal genome, of which H3.1 accounts for the most contribution. 
This is also the first evidence showing the roles of H3.1 and H3.2 in regulation of the 
dynamics of H3K9me2 and 5mC in mouse zygotes.   
4.3 Artificial introduction of H3K9me2 on H3.1 and H3.2 fails to 
block global active DNA demethylation in the paternal genome of 
mouse zygotes 
In the paternal genome, H3K9me2 is completely absent before replication and becomes rather 
sparse during replication (Lepikhov and Walter, 2004; Santos et al., 2005). Furthermore, 
recently, it shows that this small amount of H3K9me2 shields some loci of 5mC from being 
oxidized by Tet3 in the male pronucleus of mouse zyogtes (Nakamura et al., 2012). 
Therefore, the lack of H3K9me2 on a large scale is considered as the main reason to explain 
why DNA demethylation could take place preferentially in the paternal genome of mouse 
zygotes. However, so far, no direct evidence has been available to support this idea. In our 
study, both constructs of G9a are employed, full length and catalytical domain only, in order 
to introduce H3K9me2 on a global level into the paternal genome. As expected, G9aCat-NLS-
GFP could successfully introduce H3K9me2 into both pronuclei of mouse zygotes in a rather 
efficient manner. Here, the insertion of a nuclear localization sequence (NLS) from simian 
vacuolating virus 40 (SV40) into the construct helps G9aCat protein to reach both pronuclei 
in zygotes, since the deletion of NLS causes the problem of nuclear trafficking of the protein 
(Supplementary Fig. 8), consistent with the report that the NLS of G9a is located in its N-
terminal part (Esteve et al., 2005). Depite the accumulation of G9aCat-GFP in cytoplasm, it 
has no influence on H3K9me2 in both pronuclei (Supplementary Fig. 4), suggesting that the 
occurrence of transfer of dimethyl group to the K9 site of histone H3 is not in cytoplasm, but 
inside nuclear. Surprisingly, in contrast to the high efficiency of G9aCat-NLS-GFP, G9aFL-
GFP displays rather low activity for dimethylating K9 on histone H3, suggesting that G9a 
could be somehow negatively regulated via N-terminal domain in mouse zygotes, while its 
catalytical domain could easily escape from the potential inhibitors, which has also been 
proposed by Liu et al (Liu et al., 2004). Apart from the efficiency, the time point of  mRNA 
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microinjection is also critical. In our experiments, it must be done within 1.5hpf, before the 
formation of both pronuclei in mouse zygotes. Otherwise, neither G9aCat-NLS-GFP nor 
G9aFL-GFP shows its methylation activity. The reason behind remains to be explored in the 
future. Additionally, regarding the specificity, besides performing H3K9me2, G9a is also 
shown to be responsible for methylation of H3K27 to a very low extent (Patnaik et al., 2004; 
Tachibana et al., 2001; Wu et al., 2011). Here, this side effect is not further checked, because 
H3K27 methylation and 5mC are only locally overlapped with each other according to the 
genome-wide mapping of these two marks in mES cells, implying that in mouse zygotes, at 
least, H3K27methylation may not be a major player against oxidation of 5mC on a global 
level.  
Despite dramatic increase in H3K9me2 in both pronuclei, only minor but significant 
growth in 5mC was obtained correspondingly. Notably, this small amount of 5mC rescued by 
the reacquisition of H3K9me2 in both parental genomes on one hand confirmed the protection 
role of H3K9me2 in 5mC and, on the other hand, may reflect the passive dilution mechanism 
in which the replication-dependent loss of H3K9me2 could lead to the exposure of 5mC to 
Tet3 dioxygenase, which could explain the recent findings that passive DNA demethylation 
occurs in both parental genomes and Tet3-based oxidation is related to DNA replication to 
some degree (Arand et al., 2015; Guo et al., 2014b; Shen et al., 2014). Furthermore, it can be 
easily inferred that it is the loss of H3K9me2, but not the absence of Dnmt1, that causes the 
reduction in 5mC in both parental genomes. Otherwise, no increase in 5mC would be 
acquired after rescue of H3K9me2. Subsequently, the hairpin bisulfite sequencing data on the 
repetitive elements, including Long Interspersed Elements (LINE1), Intracisternal A-Particle 
Element (IAP) and Major Satellites (mSat) presented similar patterns of 5mC between 
G9aCat-NLS-GFP and non-injected groups (Supplementary Fig. 5c), further confirming the 
immunostaining results that globally active DNA demethylation is not affected given the 
broad distribution of repetitive elements across the whole genome. In addition, according to 
the literature, Liu et al. have reported that the 5mC level stays constant despite of global 
introduction of H3K9me2 into the paternal pronucleus by applying cycloheximide to mouse 
zygotes (Liu et al., 2004). This result, however, it is not convincing, because, as an inhibitor 
of protein synthesis, cycloheximide could interfere with the activities of numerous proteins in 
mouse zygotes. At least, we observed that cycloheximide could impede DNA replication and 
DNA repair pathway in mouse zygotes, which is confirmed by EdU labeling and γH2AX 
staining, respectively (Supplementary Fig. 5). As we know, both of these two factors, DNA 
replication and DNA repair pathway, could exert impact on either passive or active DNA 
demethylation. The advantage of our experiment is that we performed the detection of these 
modifications under a much cleaner background.  Collectively, the artificial introduction of 
H3K9me2 into both genomes fails to globally block active DNA demethylation, although it is 
responsible for the arrest of a small amount of 5mC which should otherwise undergo Tet3-
related passive demethylation during DNA replication.  
Next, the concerned question is that which histone H3 variants are involved in the 
G9aCat-NLS-GFP-mediated H3K9me2 process in both parental genomes, since the anti-
H3K9me2 antibody can not distinguish the epitopes among histone H3 variants, which only 
differ in four amino acids in the C-terminal domain (Hake and Allis, 2006; Kamakaka and 
Biggins, 2005). Also, based on the results above and the literature, we know that H3K9me2 
Discussion 
 
57 
 
has distinct distribution patterns across chromatin via their unique chaperones and is mostly 
enriched on H3.1 and H3.2 at least in the maternal genome (Burgess and Zhang, 2013; 
Filipescu et al., 2013). However, the detailed profiles of histone H3 variants in the paternal 
genome of mouse zygotes are not so clear. Hence, further exploration of the landscape of 
H3K9me2 in both parental genomes, especially in the paternal one, is really helpful to dissect 
the contribution of histone H3 variants to DNA demethylation. By taking advantage of the 
role of T11phos in protection of K9me2 on histone H3, it is conceivable that the introduction 
of H3K9me2 by G9aCat-NLS-GFP may be impaired by the T11A mutant of either H3.1-
GFPT11A or H3.2-GFPT11A or H3.3-GFPT11A. Indeed, co-injection experiments prove that 
H3K9me2 driven by G9aCat-NLS-GFP is disrupted by T11A mutation either on H3.1 or on 
H3.2, but not on H3.3, suggesting that H3.1 and H3.2 are involved in the dilution-based 
passive DNA demethylation in both parental genomes and further implying that H3.3 may be 
the key player responsible for Tet3-based active DNA demethylation. In summary, H3.1 and 
H3.2, which lack H3K9me2 during replication, are involved in the dilution-dependent passive 
demethylation of 5mC in a small amount in both parental genomes.  
4.4 Relation between H3.3 and active DNA demethylation in both 
parental genomes of mouse zygotes 
Since neither H3.1 nor H3.2 is responsible for global active DNA demethylation, apparently 
H3.3 becomes the most promising one. Indeed, it has been suggested by many groups because 
the deposition of H3.3 coincides with active DNA demthylation in a similar temporal and 
spatial manner, namely both starting shortly after fertilization and preferentially occurring in 
male pronucleus of mouse zygotes (Okada et al., 2010; Torres-Padilla et al., 2006; van der 
Heijden et al., 2005; Wossidlo et al., 2010; Wu and Zhang, 2010). For H3.3, it is regarded to 
be highly correlated with H3K9 acetylation according to the literature (Ahmad and Henikoff, 
2002; Loyola and Almouzni, 2007). Furthermore, in our study, the H3.3K9ac and H3K9me2 
associated regions are shown to be differentially compartmented across the chromatin, 
because H3K9ac level is not disturbed by the dramatic increase of H3K9me2 via G9aCat-
NLS-GFP in both pronuclei (Supplementary Fig. 6). Additionally, some evidence suggests 
that H3K9ac has a negative and strong correlation with DNA methylation (Bell et al., 2011; 
Wu et al., 2007; Zhang et al., 2012). Hence, it promts us to investigate to what extent H3K9ac 
could be linked to active DNA demethylation in mouse zygotes. Unfortunately, however, the 
removal of H3K9ac from H3.3 by HDAC1-GFP does not show any effect on 5mC in both 
parental genomes, indicating that H3K9ac is not a prerequisite for active DNA methylation 
pathway.  
Although acetylation at K9 of H3.3 is dispensible for Tet3-mediated oxidation 
process, it definitely could serve as a protector for the K9 site against G9aCat-NLS-GFP or 
endogenous histone methyltransferases to avoid being dimethylated in mouse zygotes. 
Therefore, the coinjection of HDAC1-GFP and G9aCat-NLS-GFP was designed to clear off 
the acetyl groups from K9 on H3.3, followed by the transfer of dimethyl groups to the target 
sites. This could probably block global active DNA demethylaiton. Again unfortunately, no 
change in H3K9me2 is observed in coinjection group compared to G9aCat-NLS-GFP alone 
injected one. For the reason behind, given the fact that the presence of T11phos shows the 
ability to protect H3K9me2, it is most probably due to the absence of T11phos on H3.3, 
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leading to the accessibility for endogenous histone demethylase to the K9 site. Based on this 
speculation, it has been assumed that K9 site has been successfully targeted by G9aCat-NLS-
GFP, but immediately attacked by some endogenous histone demethylases. In the future, 
manipulation of T11 site into a phosphorylation form and the removal of acetyl group from 
K9 site will be a possible way to introduce K9me2 for blocking Tet3-related oxidation of 
5mC, by which H3.3 could be definitely linked to active DNA demethylation. However, we 
can not fully rule out the possibility that other modifications or factors could interfere with 
G9aCat-NLS-GFP activity after the K9 site becomes vacant.     
Lastly, given the facts that T11phos is present on H3.1 and absent on H3.3, whereas 
K9ac is unrelated to H3.1 but related to H3.3, we speculate that these two histone marks may 
be mutually exclusive. To test the possibility of this potential crosstalk between H3K9ac and 
H3T11phos, the mutation of lysine 9 to glutamine (K9Q) on H3.1 was performed, which 
could mimic the acetylation form at K9 to some extent. However, H3T11phos is not impaired 
by the H3.1-GFPK9Q mutant in mouse zygotes (Supplementary Fig. 7), which excludes the 
possibility of the interaction between H3T11phos and H3K9ac. As a result, H3K9ac may not 
be responsible for the missing of H3T11phos on H3.3.   
Taken together, it is the presence of K9ac and the absence of T11phos on H3.3 that 
serve as the first and second protection mechanisms, respectively, for K9 site from being 
dimethylated by some potential histone methyltransferases, which ensures the proper 
occurrence of Tet3-based global active DNA demethylation in both parental genomes of 
mouse zygotes.  
4.5 Conclusions 
In this study, a clear picture describing the relations between histone H3 variants (H3.1, H3.2 
and H3.3), H3K9 marks (me2, me3 and ac) and DNA modifications (5mC, 5hmC) in mouse 
zygotes is presented. On one hand, H3.1 and H3.2, which are highly enriched with H3K9me2, 
are responsible for the maintenance of 5mC in an H3T11phos dependent manner in the 
maternal genome, of which H3.1 is much more dominant. On the other hand, H3.1 and H3.2, 
which are losing H3K9me2 during replication, are involved in the dilution-dependent passive 
demethylation of 5mC in a small amount in both parental genomes. As for H3.3, it is 
positively and negatively correlated with K9ac and T11phos, respectively, through which it 
successfully escapes the capture from the endogenous histone methyltransferases, ensuring 
the active DNA demethylation to occur in both parental genomes in a proper way.  
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Fig. 4.1 The schematic of relations between histone H3 variants, H3K9 modifications and DNA methylation 
4.6 Perspectives 
In the future, still many open questions are remaining to be answered. Firstly, what are the 
upstream switches for H3T11phos and H3S10phos? In other words, why do these two histone 
marks display distinctive patterns among histone H3 variants in mouse zygotes? Secondly, to 
what extent is this novel “phospho switch” conserved across the species or across the cell 
types like stem cells, somatic cells or even cancer cells? Thirdly, whether the competition 
between phosphorylation and glycosylation on H3T11 exists or not should be further 
explored. And the enzyme, OGT, should also be paid attention to in terms of its potential role 
in DNA demethylation. Fourthly, to what extent, H3T11phos or H3S10phos could be linked 
to DNA repair pathway, for dephosphorylation at S10 and T11 has been observed upon DNA 
damage (Sen and De Benedetti, 2006; Shimada and Nakanishi, 2008; Shimada et al., 2008). 
Meanwhile, how the other histone variants participate in the DNA repair pathway in mous 
zygotes is also a hotspot in the future. For example, gamma H2A.X, the the phosphorylation 
form of H2A.X on serine139, shows the preferential localization in the paternal pronucleus of 
mouse zygotes (Wossidlo et al., 2010; Ziegler-Birling et al., 2009). Fifthly, whether the 
crosstalk between methylation and phosphorylation is a general mechanism or not on the 
chromatin should be investigated, such as H3K4me1/2/3 and H3T3phos, H3K27me1/2/3 and 
H2S28phos. 
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Zusammenfassung 
Die epigenetische Reprogrammierung in der Mauszygote besteht aus der globalen 
Chromatinreorganisation sowie globalen Veränderungen der DNA Methylierung. Die 
Oxidation von 5-Methylcytosin (5mC) zu 5-Hydroxymethylcytosin (5hmC) und zu weiter 
oxidierten Basen durch die Tet dioxygenase 3 steht im paternalern und maternalen Genom in 
Korrelation mit dem Status der Methylierung von Lysin 9 an Histon 3 (H3K9me2/3). Es 
wurde gezeigt, dass die H3 Histonvarianten, H3.1, H3.2, H3.3, asymmetrisch und dynamisch 
in das Chromatin intergriert werden. Dies kann auf eine DNA-replikationsabhänige oder –
unabhängige Weise geschehen. In dieser Arbeit wurde die dynamische Kontrolle von 
H3K9me2 und von DNA Modifikationen in Relation zum Phosphorylierungsstatus an H3S10 
und H3T11 sowie der Histon H3 Varianten in der Mauszygote untersucht. Es konnte gezeigt 
werden, dass H3.1 und H3.2 das Hauptziel für die Dimethylierung von Lysin 9 sind. Dieser 
Prozess ist abhängig vom Phosphorylierungsstatus von H3S10 und H3T11. H3K9me2 
behindert die Oxidation von 5mC zu 5hmC im maternalen Genom der Mauszygote. Während 
der Replikation wird K9me2 an beiden Histonvarianten (H3.1 und H3.2) reduziert was mit 
einer replikationsabhängigen passiven DNA Demethylierung in beiden parentalen Genomen 
einhergeht. Für H3.3 wurde beobachtet, dass die Phase der aktiven DNA Demethylierung in 
beiden parentalen Genomen in Verbindung zu deutlichen und einzigartigen Dynamiken von 
K9ac und T11phos steht.Zusammenfassend lässt sich sagen, dass die Daten dieser Arbeit 
darauf hinweisen, dass ein Spektrum aus verschiedenen Histonvarianten und –modifikationen 
die aktive und passive Reprogrammierung in der Mauszygote kontrollieren. 
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Summary 
In mouse zygotes, reprogramming involves chromatin reorganization and changes in the DNA 
modifications. The conversion of 5-methylcytosine (5mC) to 5-hydroxymethycytosine 
(5hmC) and further oxidized forms by the Tet dioxygenase 3 (Tet3) in maternal and maternal 
genomes has been associated to the modification status of histone H3 at lysine 9 
(H3K9me2/3). It has also been shown that histone H3 variants H3.1, H3.2, H3.3, are 
asymmetrically and dynamically deposited into chromatin in DNA replication dependent and 
independent manner in the mouse zygote. Here we investigate the dynamics of H3 variants 
during epigenetic reprogramming in the zygote, in particular the control of H3K9me2 in 
relation to the phosphorylation status at H3S10 and H3T11 and their impact on changes in 
DNA modifications in mouse zygotes. We find that H3.1 and H3.2 are the prime targets for 
K9me2 modification impeding the oxidation of 5mC into 5hmC in an H3T11phos dependent 
manner in the maternal genome of mouse zygotes. Upon replication, K9me2 on both H3.1 and 
H3.2 is reduced and paralleled by a replication-dependent passive DNA demethylation in both 
parental genomes. For H3.3 we observe that phases of active DNA demethylation in both 
parental genomes are linked to distinct and unique dynamics of K9ac and 
T11phosphorylation, respectively. In summary our data indicate that a differential variant 
specific modification spectrum controls active and passive reprogramming processes in 
mouse zygotes. 
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Supplementary Fig. 1 Influence on H3K9me2 by BIX 01294. a, Representative images of treated- and 
untreated zygotes stained with antibodies agaist H3K9me2. H3K9me2, red; Dapi, blue; m, the maternal 
pronucleus; p, the paternal pronucleus; pb, polar body. b, Quantification of H3K9me2 signal normalized against 
Dapi signal in both parental genomes of zygotes at PN4/5. Non-treated group, blue; treated group, red; Error bars 
indicated s.d.. For each group, at least 10 zygotes were analysed from at least two repeated experiments. 
 
 
Supplementary Fig. 2 Influences on H3K9me3 and nucler topology by Chaetocin treatement in mouse 
zygotes. Representative images of PN4/5 stage zygotes stained with antibodies against H3K9me3. H3K9me3, 
red; Dapi, blue. m, the maternal pronucleus; p, the paternal pronucleus; pb, polar body. For each group, at least 
10 zygotes were analysed from at least two repeated experiments.  
 
 
Supplementary Fig. 3 Quantification of H3S10phos and H3T11phos in mouse zygotes. Quantificaiton of 
H3S10phos and H3T11phos signals normalized against Dapi signals in both parental genomes of zygotes in 
different PN stages. Solid lines, H3S10phos; dashed lines, H3T11phos; red and pink, the paternal pronuclei; blue 
and green, the paternal pronuclei. For each group, at least 10 zygotes were analysed from at least two repeated 
experiments.   
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Supplementary Fig. 4 No influence on H3K9me2 in zygotes by microinjection of G9aCat-GFP. 
Representative images of PN4/5 stage zygotes stained with antibodies against H3K9me2. H3K9me2, red; Dapi, 
blue; m, the maternal pronucleus; p, the paternal pronucleus; pb, polar body. For each group, at least 10 zygotes 
were analysed from at least two repeated experiments. 
 
Supplementary Fig. 5 Influences on DNA replication and DNA repair by cycloheximide treatement in 
mouse zygotes. Representative images of PN4/5 stage zygotes labeled with Edu and stained with antibodies 
against gamma-H2AX. Edu, green; gamma-H2AX, red; Dapi, blue. m, the maternal pronucleus; p, the paternal 
pronucleus; pb, polar body. For each group, at least 10 zygotes were analysed from at least two repeated 
experiments. 
 
Supplementary Fig. 6 No Influence on H3K9ac in zygotes by microinjection of G9aCat-NLS-GFP. 
Representative images of PN4/5 stage stained with antibodies against H3K9ac. H3K9ac, red; Dapi, blue. m, the 
maternal pronucleus; p, the paternal pronucleus; pb, polar body. For each group, at least 10 zygotes were 
analysed from at least two repeated experiments. 
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Supplementary Fig. 7 Impacts on H3T11phos and H3K9me2 in zygotes by microinjection of H3.1-
GFPK9Q. a. Representative images of PN4/5 stage zygotes stained with antibodies against H3T11phos. b. 
Representative images of PN4/5 stage zygotes stained with antibodies against H3TK9me2.  H3T11phos or 
H3K9me2, red; Dapi, blue. m, the maternal pronucleus; p, the paternal pronucleus; pb, polar body. For each 
group, at least 10 zygotes were analysed from at least two repeated experiments. 
 
Supplementary Fig. 8 Nuclear localization of the injected constructs fused with GFP. a. Representative 
images of PN4/5 stage zygotes microinjected with H3.1/2/3-GFPS10A and H3.1/2/3-GFPT11A, respectively. b. 
Representative images of PN4/5 stage zygotes microinjected with G9aFL-GFP, G9aCat-NLS-GFP and G9aCat-
GFP, respectively. c. Representative images of PN4/5 stage zygotes microinjected with HDAC1-GFP and 
HDAC2-GFP, respectively. For each group, at least 10 zygotes were analysed from at least two repeated 
experiments. 
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Abbreviations                      
APS (10%) Ammonium persulfate 
BSA Bovine serum albumin 
bp Base pair 
DAPI 4',6-diamidino-2-phenylindole 
DAB Diaminobenzidin  
Dnmt DNA methyltransferase 
dNTPs Deoxyribonucleotide triphosphates  
°C Degree Celsius 
DMSO Dimethyl sulfoxide  
5% DMDCS  Dimethyldichlorosilane  
DTT Dithiothreitol 
EDTA Ethylenediaminetetraacetic acid 
EdU 5-ethynyl-2'-deoxyuridine 
5caC 5-Carboxyl-Cytosine 
5fC 5-Formyl-Cytosine 
5hmC 5-Hydroxymethyl-Cytosine 
5mC 5-Methyl-Cytosine 
g Gram 
Glycerol Carl Roth, Karlsruhe, Germany 
h Hour 
hCG  Human chorionic gonadotropin 
HDACs Histone deacetylase 
HMT Histone methyltransferase 
HP1 Heterochromatin protein 1 
hpf Hours post fertilization 
IAP Intracisternal A-particle element 
IF Immunofluorescence 
IPTG Isopropyl β-D-1-thiogalactopyranoside 
IVF In vitro fertilization 
IVT In vitro transcription 
L Liter 
LINE1 Long interspersed element 
µg Microgram 
mg Milligram 
min Minute 
µl Microliter 
ml Milliliter 
M Molar 
µM Micromolar 
mM Millimolar 
mRNA Messenger RNA 
mSat Major satellite 
ng Nanogram 
% Percentage 
PCR Polymerase chain reaction 
PMSG  Pregnant mare's serum gonadotropin 
RT Room temperature 
RT Reverse transcription 
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SDS Sodium dodecyl sulfate  
TEMED Tetramethylethylenediamine 
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